ODS Hires New Medical Director

ODS has hired William E. Johnson, M.D, as the company’s newest Medical Director.

Dr. Johnson is a thoracic and vascular surgeon. He attended medical school at the University of Southern California, Los Angeles. He completed his residency in general surgery at Los Angeles County Hospital+USC Medical Center, and fellowship in thoracic surgery at Beth Israel Hospital, Harvard. At ODS, Dr. Johnson will join Csaba Mera, M.D., as a second Medical Director across the health plan and will focus on utilization management activities.

“I am looking forward to working with such a high-caliber company on such an important area,” Dr. Johnson said. “I believe that by continuing to strengthen our communication among patients, providers and hospitals, we can help find solutions to improving the practice of evidence-based medicine which would enhance chronic disease management and improve the quality of healthcare.”

ODS Senior Vice President and Chief Marketing Officer C.J. McLeod said Dr. Johnson will provide additional in-house expertise for the company.

“Dr. Johnson is highly regarded in the healthcare community,” McLeod said. “As we continue to grow, it is our goal to provide the best access to care and health expertise for our members. Dr. Johnson’s expertise and surgical background will help us better serve our members and providers.”

About ODS

ODS is a multifaceted organization that provides medical, pharmacy, dental, vision and professional liability insurance products, along with a variety of business services including benefits administration. ODS serves more than 1 million members. Founded in 1955, ODS is Oregon’s leading dental plan and one of the state’s leading medical plans. ODS is a founding member of the Delta Dental Plans Association, the nation’s largest and most experienced dental benefits provider. ODS is headquartered in Portland and has offices in Medford, Ore., Milwaukie, Ore., Bend, Ore., and La Grande, Ore., as well as in Bothell, Wash., and Anchorage, Alaska. For more information, visit www.odscompanies.com.

Rite Aid Introduces Discount Card for Prescription Drugs

US-based pharmacy chain Rite Aid has announced that customers will be able to realize savings on more than 10,000 prescription drugs with the free Rite Aid RX Savings Card available at all Rite Aid drugstores across the US, beginning September 29, 2008.

The card, which requires no membership fee and is free to anyone who enrolls, also provides an immediate 10% discount on more than 3,200 Rite Aid brand products, including 1,500 over-the-counter medications.

Cards can be obtained at any Rite Aid store nationwide. Card benefits are effective as soon as the application is completed and turned into a Rite Aid pharmacy.

Benefits of the free card include access to more than 400 generic medications at $8.99 for a 30-day supply and $15.99 for a 90-day supply for each prescription; a 20% discount on all other generic medications and brand drug prescriptions; and a 30-day supply of select generic oral contraceptives for $19.99.

Rite Aid said that the savings card will especially benefit those who have no or limited prescription insurance. Others who will find particular benefit from the card are those whose prescription plan does not cover certain drugs or who have reached their benefit limits. Persons receiving benefits from publicly funded health care programs are ineligible.

Customers can get a list of the medications covered by the savings card at any Rite Aid pharmacy. The card can be used for prescriptions for any member in a family, including pets, but cannot be used in conjunction with prescription insurance.

CDC Selects Abt Associates to Support National Birth Defects Prevention Study

CAMBRIDGE, Mass., Sept. 26 /PRNewswire/ — The Centers for Disease Control and Prevention (CDC) has awarded Abt Associates contracts totaling $4.9 million to provide data collection and project management services for the on-going National Birth Defects Prevention Study. The purpose of the study, which began in 1997, is to collect data that can help identify risk factors and patterns in the occurrence of birth defects. Abt SRBI, the company’s survey research subsidiary, will complete all of the data collection for the assignment.

Birth defects, which develop during pregnancy, are the primary cause of infant mortality in the United States, and have a serious impact on the health and well-being of children born with such defects. Although birth defects are common, affecting approximately 1 in 33 babies, or about 3% of all babies born in the United States, little is know about their cause.

The National Center on Birth Defects and Developmental Disabilities (NCBDDD) at the CDC has implemented a collaborative effort to gather surveillance data from ten centers around the United States. The centers work together to conduct the National Birth Defects Prevention Study. The study uses a case control framework to interview mothers, facilitate physician review of medical case histories for sampled children, and collect biological specimens from participating families.

“We are very pleased to have the opportunity to assist the CDC with this important study,” said Deborah Walker, Abt Associates Vice President and Public Health Practice Leader. “Abt Associates has a long history of survey instrument development, data collection and tracking, and achieving high survey response rates. We will be applying our multidisciplinary expertise in areas such as research design, surveillance, data management, biostatistics, and clinical and laboratory methods to assist with this study and ultimately reduce the incidence of birth defects.”

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.

Abt Associates

CONTACT: Peter Broderick, Vice President, Corporate Communications ofAbt Associates, +1-617-349-2882, [email protected]

Web site: http://www.abtassociates.com/

Asda to Launch Spirulina-Based Food Coloring As Part of Natural Baking Range

UK supermarket chain operator Asda has announced that it is launching a natural baking range featuring spirulina-based coloring at its stores in September 2008.

Asda said that the company’s chefs, who were looking for a natural source to create bottles of blue food coloring, are using the spirulina blue-green algae as part of its new natural baking range. Spirulina, which is known for its nutritional properties, was chosen after months of research at Asda.

Asda said that it will be first supermarket to introduce its own all-natural baking range. The revolutionary range is reported to be entirely free of artificial colors and flavors, bringing it into line with all Asda’s food and drink products which are claimed to be free of artificial colors and flavors.

The new baking range has been a year in the making, with significant product testing to ensure each item met strict quality controls.

Asda’s new natural baking range, which will be launched on September 29, 2008, including 13 food colors and flavorings, sprinkles, sugar balls, piping and writing icing. In addition, a selection of fun decorations are available for young bakers, with Little Hero products for boys and Little Princess for girls. Prices in the range start at GBP0.52 for the natural food coloring and GBP0.60 for sprinkle decorations.

WWF-Canada: NAFO Decisions Undermine Cod Recovery

The Northwest Atlantic Fisheries Organization (NAFO) made decisions that will undermine cod recovery during their annual meeting in Vigo Spain this week. The status of cod on the southern Grand Banks remains severely depleted despite 14 years under fishing moratorium. The outcomes from the meeting demonstrated that there still lacks a sense of urgency to halt levels of bycatch that threaten the recovery of this stock.

Last year NAFO adopted a southern Grand Banks cod recovery strategy to reduce bycatch of cod by 40 per cent. This year NAFO made decisions that will lead to increases in cod bycatch in 2009 without knowing whether this target was met. Of most concern were decisions to increase the yellowtail flounder catch limit, and maintain the thorny skate limit well above scientific recommendations. These decisions have the potential to directly impact cod in 2009.

NAFO did take some important steps towards the protection of vulnerable habitats, such as coldwater coral forests. For example, measures were adopted to limit the impacts of bottom fishing in new fishing areas and provide for the protection of corals when encountered. New measures were also put in place to protect the Fogo Seamounts (undersea mountains located southwest of the Grand Banks). These efforts were strengthened by commitments to conduct new sea floor mapping and research.

“The decisions affecting cod bycatch are not consistent with NAFO’s commitments to the precautionary and ecosystem management,” said Dr. Robert Rangeley, Vice President Atlantic, WWF-Canada. “The only hope we can see for this situation is for NAFO and member countries to immediately implement more stringent measures to reduce cod bycatch in their fleets. Continuing with the status quo will surely wipe out the promising 2005 year class and the best opportunity for the recovery of this stock.”

The recovery of the southern Grand Banks cod population will depend on the survival and reproduction of pulses of young cod in the population, such as occurred this year. Increases in bycatch in 2009 will jeopardize the survival of these young fish.

 Contacts: WWF-Canada Stacey McCarthy Communications Specialist, Atlantic Region (902) 482-1105 x 41 or Cell: (902) 209-6457 Email: [email protected]  WWF-Canada Robert Rangeley Vice President, Atlantic (902) 482-1105 x 23 or Cell: (902) 401-1569 Email: [email protected] Website: www.wwf.ca

SOURCE: WWF-Canada

Examine the Philippines Pharmaceuticals and Healthcare Industry With This Essential Q3 2008 Report

Research and Markets (http://www.researchandmarkets.com/research/5b184d/philippines_pharma) has announced the addition of the “Philippines Pharmaceuticals and Healthcare Report Q3 2008” report to their offering.

The Philippines remains ranked tenth in the BMI’s Q308 Business Environment Rankings of 14 key markets in the Asia Pacific region, illustrating limited opportunities and substantial risks to operating in the country despite the high prices of medicines. The market size – of around US$2.6bn in 2007 and with a forecast value of US$4.5bn in 2012 – is relatively unremarkable in global terms, with values further threatened by the recently signed Universally Accessible Cheaper and Quality Medicines Act of 2008 (previously known as the ‘Cheaper Medicines Bill’). The development has led BMI to upwardly revise its forecasts for the generics market, which is expected to top US$890mn by 2012. However, foreign research-based companies will undoubtedly criticise new legislation as they will lose the right to apply for patents based on newly discovered uses of a known drug, as well as face price caps on various medicines and an increase in parallel imports.

Therefore, regulation remains in need of improvement with the Philippines in 2008 once again featuring on the ‘Watch List’ of countries with a problematic intellectual property (IP) environment, as judged by US drug industry association PhRMA. The country continues to be criticised for the prevalence of counterfeit drugs, among other issues. Given that only 30% of the population in the Philippines enjoy unrestricted access to essential drugs, the situation is unlikely to be significantly improved in the first half of the forecast period at least. The Philippines also has one of the lowest investments in health out of any country in the world, which will continue to negatively impact the development of its pharmaceutical

market.

Other issues facing companies active in pharmaceutical manufacturing and retail include the increasingly challenging operating environment for small and medium-sized (SME) drugstores. One of the key problems is the rising price of basic commodities such as foodstuffs, which is likely to result in lower spending on pharmaceuticals deemed non-essential items. Nevertheless, drugstores are attempting to overcome such problems by amending their layouts, bulk-buying of medicines and pooling staff training exercises. However, it is unlikely that all outlets will be able to deal with such pressures, especially in the face of the strengthening of local currency against the US dollar. An additional problem is the new law stipulating a 20% discount on medicines for senior citizens. However, drugstores are suffering as the government only reimburses 32% of the discount.

On a positive note, a recent report by UK-based charity Save the Children stated that the Philippines as well as Peru is achieving the best results among developing countries in their treatment of childhood diseases and infant healthcare in general. In the Philippines, 31% of children under the age of five are not getting basic healthcare such as vaccines and drugs – the smallest proportion of any country in the ninth annual State of the World’s Mothers report. Since 1990 the Philippines has achieved a remarkable 48% reduction in its under-fives death rate.

Executive Summary:

BMI’s Philippine’s Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Philippines’ pharmaceuticals and healthcare industry.

Key Topics Covered:

Executive Summary

-Philippines Pharmaceutical And Healthcare Industry SWOT

-Philippines Political SWOT

-Philippines Economic SWOT

-Philippines Business Environment SWOT

-Pharmaceutical Business Environment Ranking

-Table: Asia Pacific Pharmaceutical Business Environment Ratings

Limits Of Potential Returns

-Risks To Realisation Of Returns

-The Philippines – Market Summary

-Regulatory Regime

-Recent Regulatory Developments

-Intellectual Property Regime

-IP Shortcomings

-IP Disputes

-Counterfeit Drugs

-Pricing And Reimbursement Regime

-Parallel Trade

-International Co-operation

-Industry Trends And Developments

-Epidemiology

-Communicable Diseases

-Healthcare Sector

-Healthcare Sector Financing

-Corruption

-Medical Tourism

-Pharmaceutical Sector

-Table Clinical Trial Considerations In Asia

-Domestic Industry

-Foreign Companies

-Biotechnology

-Recent Biotechnology Developments

-Traditional Medicines

-Pharmaceutical Retail

-Recent Developments in Pharmaceutical Retail

-Medical Devices

Industry Forecast Scenario

-Overall Market Forecast

-Table: Philippines – Drug Expenditure And Prescription Market Indicators (US$mn unless otherwise stated)

-Key Growth Factors – Industry

-Table: Philippines’ Health Expenditure Forecasts

-Economic Activity

-Table: Philippines Economic Activity

-Patented Market Forecast

-Table: Philippines’ Patented Drugs Market Indicators (US$mn unless otherwise stated

-Generics Market Forecast

-Table: Philippines’ Generics Market Forecasts

-OTC Market Forecast

-Table: Philippines’ OTC Drugs Market Indicators (US$mn unless otherwise stated)

-Export/Import Forecasts

-Table: Philippines’ Pharmaceuticals Exports & Imports Forecasts (US$mn

-Other Healthcare Data Forecasts

-Table: Philippines – Other Health Indicators

-Key Risks To BMI’s Forecast Scenario

-Competitive Landscape

-Table: Leading Firms And Medicines In the Philippines, Q405

Company Monitor

-Leading Multinational Manufacturers

-GlaxoSmithKline Philippines

-Pfizer

-Novartis

-Merck & Co

-Sanofi-Aventis

-Abbott Laboratories

-Bristol-Myers Squibb

-Wyeth

-Eli Lilly

-Indigenous Manufacturers

-Unilab

-Pascual Laboratories

-Pacific Pharma Generics

-MediChem Pharmaceuticals

BMI Forecast Modelling

-How We Generate Our Pharmaceutical Industry Forecasts

-Pharmaceutical Industry

-Pharmaceutical Business Environment Ratings Methodology

-Ratings Overview

-Table: Pharmaceutical Business Environment Indicators

-Weighting

-Table: Weighting Of Components

-Sources

Companies Mentioned:

-GlaxoSmithKline Philippines

-Pfizer

-Novartis

-Merck & Co

-Sanofi-Aventis

-Abbott Laboratories

-Bristol-Myers Squibb

-Wyeth

-Eli Lilly

-Unilab

-Pascual Laboratories

-Pacific Pharma Generics

-MediChem Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/5b184d/philippines_pharma

Sagent Acquires Rights to Infusive Technologies’s Syringe Technology

Sagent Pharmaceuticals, a privately held specialty pharmaceutical company, has acquired Infusive Technologies’s proprietary, patented, multi-chamber, sequential dose syringe technology.

Sagent said that its dual-chamber syringe enables the sequential administration of two separate intravenous medications with a single syringe push, thereby replacing two syringes with one.

The benefits of this single delivery capability include increasing the speed and ease of drug administration, reducing risk of hospital acquired infection by reducing the number of connections, lowering the risk of drug administration or sequence errors, and quicker delivery of emergency medicines requiring an immediate sequential flush, added Sagent.

The unique dual-chamber syringe can accommodate lyophilized, powder or liquid formulations in the front chamber combined with diluents, saline or heparin flush in the rear chamber, according to Sagent.

Jeffrey Yordon, chairman, founder and CEO of Sagent Pharmaceuticals, said: “We believe that this dual-chamber syringe technology has far reaching benefits which will allow healthcare providers to deliver multiple drugs more quickly and more safely than with multiple syringes. The simplicity and functionality of this device yield near-term opportunities for use with both proprietary and multi-source pharmaceutical products.

“We welcome Infusive’s CEO, Bradley Robinson, to Sagent in his role as president of Sagent’s newly created device division, Sagent Technologies. The creation of Sagent Technologies marks an important milestone for the company, as it enhances our ability to provide a broad range of differentiated product offerings to healthcare providers.”

Nokia Launches New Software to Help Public Sector and NGOs

Finland-based Nokia has launched Nokia Data Gathering, a new software solution to help public sector and non-governmental organizations in collecting data on critical issues such as disease outbreaks or disaster relief via mobile devices.

Nokia said that the Amazonas State Health Department in Brazil will be the first to use the solution as part of its fight against dengue fever in the city of Manaus in northern Brazil.

The Nokia Data Gathering software will be available to public sector organizations and non-governmental organizations (NGOs) free of charge. It can be used to create tailored questionnaires and distribute them to multiple mobile phones using a normal mobile network. Field personnel surveying local conditions can complete the questionnaires and immediately transmit their findings to a central database. The system also allows organizations to geo-tag data with GPS location information to build a more detailed picture of very local conditions, said Nokia.

The software was developed by Nokia and Instituto Nokia de Tecnologia, a non-profit R&D center in Brazil. Nokia will be donating licenses for the Nokia Data Gathering software to public sector organizations and NGOs.

Gregory Elphinston, director of community involvement at Nokia, said: “Sound decisions are based on the analysis of fresh, accurate data. However, for organizations with a remote or mobile workforce, this is easier said than done.

“Information related to health, agriculture and environmental conditions is often recorded on paper, transported and transcribed, in a process that can take months and result in errors. Nokia Data Gathering aims to improve accuracy and deliver information in near real-time, helping decision-makers to improve the delivery of social services.”

Indevus and FDA Agree on Path Forward for NEBIDO(R)

LEXINGTON, Mass., Sept. 26 /PRNewswire-FirstCall/ — Indevus Pharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) with regard to the additional data and risk management strategy that will lead to re-submission (complete response) of the New Drug Application (NDA) for NEBIDO(R) in the first quarter of calendar 2009. The re-submission database will include experience from over 14,000 injections in more than 2,600 patients, all of which come from existing clinical trials conducted in the U.S. and post-marketing studies that have been conducted in Europe. FDA stated that the number of patients and the number of injections of testosterone undecanoate from these studies appear to provide an adequate size database to determine the precise incidence of serious post-injection, oil-based reactions.

Indevus and FDA also agreed on an education plan to minimize the risks associated with the clinical use of testosterone undecanoate intramuscular injection, namely, to reduce the incidence and/or severity of the serious oil- based reactions. Further, Indevus and FDA agreed to obtain skin-testing data to characterize an allergic component to the drug or any of its excipients in certain patients. Indevus has also agreed to conduct a large, simple post- marketing study of the safety of NEBIDO in approximately 10,000 patients.

“We are very pleased that we can provide to FDA additional data from existing clinical trials to satisfy FDA’s desire to understand the incidence of these rare oil-based reactions, without the need to conduct new clinical trials prior to resubmission or approval,” stated Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. “FDA also agreed with our outline of the proposed risk mitigation plans that included appropriate labeling description of intramuscular injection technique, adequate labeling information regarding allergic and oil-based reactions, and the commitment to conduct a large, simple post-marketing study. Risk mitigation plans are now commonly added to approval of new drugs and our agreed plans are consistent with FDA’s new initiatives for the management of safety of new drugs. Given a six month FDA review time, assuming approval, we will be in a position to launch NEBIDO with our sales force in the fourth quarter of calendar 2009. We remain enthusiastic about the marketplace opportunity for a long-acting injectable testosterone therapy and we expect the introduction of NEBIDO to have a significant positive impact on the Company’s business plan.”

About NEBIDO(R)

NEBIDO(R) is a long-acting depot preparation of testosterone undecanoate under development for the treatment of male hypogonadism. NEBIDO is expected to be the first long-acting testosterone preparation available in the U.S. in the growing market for testosterone replacement therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005.

About Indevus

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company’s approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate cancer, SUPPRELIN(R) LA for central precocious puberty, and DELATESTRYL(R) to treat male hypogonadism. The Indevus development pipeline contains multiple compounds within the Company’s core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include, VALSTAR(TM) for bladder cancer, NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly and carcinoid syndrome.

Forward Looking Statements

Except for the descriptions of historical facts contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause the Company’s actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties are set forth in the Company’s filings under the Securities Act of 1933 and the Securities Exchange Act of 1934 under “Risk Factors” and elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, VANTAS and SUPPRELIN LA; need for additional funds and corporate partners, including for the development of our products; effectiveness of our sales force; competition and its effect on pricing, spending, third-party relationships and revenues; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and clinical trials; risks associated with being a manufacturer of some of our products; risks associated with contractual agreements, particularly for the manufacture and co-promotion of SANCTURA and SANCTURA XR and the manufacture of NEBIDO, VANTAS, SUPPRELIN LA and VALSTAR; reliance on intellectual property and having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement policies and/or rates for SANCTURA, SANCTURA XR, VANTAS, SUPPRELIN LA, DELATESTRYL and any future products; acceptance by the healthcare community of our approved products and product candidates; uncertainties relating to clinical trials, regulatory approval and commercialization of our products, particularly SANCTURA XR, NEBIDO, and VALSTAR; product liability and insurance uncertainties; risks relating to the Redux-related litigation; history of operating losses and expectation of future losses; uncertainties relating to controls over financial reporting; valuation of our Common Stock; risks related to repayment of debts; risks related to increased leverage; general worldwide economic conditions and related uncertainties; and other risks. Indevus undertakes no obligation to publicly update any forward- looking statement, whether as a result of new information, future events or otherwise.

   Contact:   Michael W. Rogers                  Robin L. DeCarlo   EVP and Chief Financial Officer    Director, Corporate Communications   (781) 861-8444                     (781) 402-3405  

Indevus Pharmaceuticals, Inc.

CONTACT: Michael W. Rogers, EVP and Chief Financial Officer,+1-781-861-8444, or Robin L. DeCarlo, Director, Corporate Communications,+1-781-402-3405, both of Indevus Pharmaceuticals, Inc.

Web site: http://www.indevus.com/

Piqua YWCA to Honor 3 Women at Women of Excellence

By Staff Report

PIQUA — The YWCA of Piqua will recognize Sondra Christian, a registered nurse who lives in Troy, and Ginger Godfrey of Bradford as the 2008 Women of Excellence. Elizabeth Okrutny of Tipp City was named as the Young Woman of Tomorrow.

They will be honored at the 12th Women of Excellence Awards Luncheon on Oct. 16 at the Piqua Country Club. The keynote speaker will be Megan A. Wolfe, author and women’s advocate.

Tickets are $50.

For more information about the luncheon or to reserve a ticket, stop at the YWCA Piqua, 418 N. Wayne St., or call (937) 773-6626. Seating is limited.

Sondra Christian

Sondra “Sandy” Christian is director of nursing for the Miami County Health District. A county native, she graduated from Miami East High School and Miami Valley School of Nursing. She is married to Doug Christian. They have two adult daughters, Kelli and Beth.

Jim Luken, county Health Commissioner, said Christian has been instrumental in planning and maintaining programs in the Well Child Clinic, the Women’s Wellness Program, the Child Immunization program and, most recently, the pandemic flu preparedness/ education.

She oversees the work of a staff of 12 including public health nurses and support staff. She is involved in the new dental clinic opening in October and the Miami County Health Partners Clinic.

Ginger Godfrey

Ginger Godfrey, a Bradford native, is a master organizer. In 2005, she organized opening a community soup kitchen, an operation offering Wednesday evening meals and home deliveries.

Last year, the Bradford Railroad Museum requested her help in generating money to cover museum expenses.

As a result, Hobo Days was founded by Godfrey in September 2007, with a wine-tasting event, art auction and other activities.

She is a dental hygienist and is active in the Bradford Church of the Brethren as well as a garden club she started this year.

Godfrey and her husband, Gary, have three adult children: a son, J.K., and two daughters, Kelly and Jennifer.

Elizabeth Okrutny

Elizabeth Okrutny, a graduate of Tippecanoe High School, is a junior at Ohio Northern University. She is majoring in forensic biology with a minor in art and hopes to combine the interests working in facial reconstruction and age progression.

Okrutny is a life member of the Girl Scouts and active in the Children of the American Revolution. As a service project, she worked with the Ohio State Parks K-9 officers to raise funds for installation of temperature-monitoring systems for cruisers that transport the dogs.

She spent this past summer studying in Korea. Back on the ONU campus, she is a member of Alpha Xi Delta Sorority and the World Student Organization.

Okrutny is the daughter of Jeff and Teri Okrutny.

(c) 2008 Dayton Daily News. Provided by ProQuest LLC. All rights Reserved.

The Role of Environmental Health in Disaster Management

By Eldridge, Deanna Tenkate, Thomas D

Abstract Even though environmental health is widely considered to be an integral component of disaster management, limited research on this topic has been conducted. Using a qualitative approach, the authors conducted in-depth interviews of practitioners in Queensland, Australia, to explore the role of environmental health in disaster management and determine how those internal and external to the profession perceive this role. The major themes that emerged described a process in which the “view of health” is socially constructed, and this process is instrumental in shaping perception of the environmental health role in disaster management. The authors also found that the role of environmental health in disaster management is experiencing renegotiation due to a complex process of challenging the socially constructed view of health, raising the profile of the profession, and achieving increased representation in disaster management. Ultimately, increased recognition and a heightened profile of environmental health will result in a more effective disaster management system and will carry over into day- to-day activities.

Introduction

In recent years, disaster management has been at the forefront of discussions in Australia and many other countries. This is in part due to a realization that the previous arrangements may not have been adequate to meet the range of emerging threats. The terrorist attacks of September 11, 2001; the Bali bombings in 2002 and 2005; the London bombings in 2005; and fears of bioterrorism have resulted in a changed environment for disaster management in Australia and internationally (Bradt, Abraham, & Franks, 2003; Burkle, 2006; Caldicott & Edwards, 2002; Fisher & Burrow, 2003; Noji, 2001; Vinen, 2003).

Disaster management structures must continue to be effective for natural disasters, such as cyclones, bushfires, tsunamis, infrastructure or technological failure, and heat waves (Abrahams, 2001; Emergency Management Australia, 2005). These structures also need to ensure that appropriate mechanisms are in place to respond to emerging diseases, such as avian influenza, SARS, and the threat of pandemic influenza (Loeb, 2004; Srinivasan et al., 2004). The changing landscape in disaster management means that new hazards must be identified and protected against in addition to existing hazards, requiring extensive reviews of disaster management structures (Armstrong, 2003; Berg, 2004; Caldicott & Edwards, 2002; Emergency Management Australia, 2003).

Despite the integral role of environmental health in disaster management, the specific role of environmental health practitioners in disaster management was rarely investigated until after the terrorist attacks of September 11, 2001. Since then, a substantial amount of literature has emerged; however, this has consisted primarily of descriptive accounts, opinion pieces such as editorials and interviews, and reports (Berg, 2004; Fabian, 2002; Fabian, 2004; Forsting, 2004; Lyman, 2003). Most of this literature focuses on the roles of environmental health professionals in the context of terrorism or bioterrorism; however, the emerging themes can be applied to many large-scale disaster situations (Fabian, 2002; Forsting, 2004; Khan, Morse, & Lillibridge, 2000; Noji, 2005; Noji & Toole, 1997).

It is clear from the literature that a number of issues for environmental health in relation to disaster management require further research. The most common theme is that ambiguity exists about the role of environmental health in disaster management, particularly in its distinction from the broader roles of public health. This ambiguity is exacerbated by a lack of research on this topic (Fabian, 2002; Forsting, 2004; Lyman, 2003). Other themes that have emerged relating to environmental health generally and in the context of disaster management specifically include the following:

* the professionalization of environmental health (Brimblecombe, 2003; Kotchin, 1997; Roberts, 1996);

* the representation, profile, and visibility of the environmental health discipline (Berg, 2004; Emergency Management Australia, 2003; Fabian, 2002; Fabian, 2004; Logue, 1996; Lurle, Wasserman, & Nelson, 2006; Lyman, 2003);

* debate surrounding the separation of environmental health from public health (Kotchin, 1993; Kotchin, 1997; Leggat, 2003; Logue, 1996);

* the power and politics involved in role negotiation (Berg, 2004; Bashir, Lafronza, Fraser, Brown, & Cope, 2003); and

* the top-down approach to constructing disaster plans (Bashir et al., 2003; Rasmussin & Jansen, 1998).

Given the lack of research into an increasingly important topic, we conducted a rigorous qualitative study during 2005 in Queensland, Australia, to explore the role of the environmental health discipline in relation to disasters and how others perceive this role. This study also explored the broader role of environmental health and the perceptions of both environmental health practitioners and those external to environmental health.

Methods

This research employed a rigorous qualitative approach in which in-depth interviews were conducted with 10 experienced practitioners from the areas of disaster management, environmental health, and public health.

Qualitative Methodology

This study was grounded in the epistemologica! principles of social constructionism and guided by the theoretical tenets of symbolic interactionism. The research framework is depicted in Figure 1. Social constructionist inquiry is concerned with discovering how individuals and groups create their perceived realities (Gergen, 2003) and was applied in this study because the focus was on the function of social processes in shaping the role of environmental health in disaster management. Furthermore, people’s knowledge of environmental health dictates how they act towards and within the environmental health profession.

Symbolic interactionism is a theoretical perspective that provides a link between the examination of the social processes that shape knowledge and the ways in which human beings act upon, reproduce, and modify that knowledge. The foremost objective of symbolic interactionism is to portray and understand the construction of meaning.

A number of criticisms of symbolic interactionism, exist, however, with one-that it neglects methodological issues- particularly relevant to this study. This criticism led to the development of grounded theory, which is a systematic method for organization and analysis of qualitative data (Crotty, 1998; Liamputtong & Ezzy, 2005). Grounded theory was applied in this study, as it provides researchers with a way to study the behavior and interaction of humans, in order to “conceptualize behavior in complex situations, to understand unresolved or emerging social problems, and to understand the impact of new ideologies (Chenitz & Swanson, 1986).”

Sampling and Recruitment

Participants for this study were recruited through the combined use of two sampling methods: purposive and snowball sampling. Purposive sampling is a deliberately non-random method of participant recruitment, ft is commonly used in qualitative research and is particularly useful for obtaining a sample of a group of people with a similar, specific characteristic for study and when experience of a phenomenon is of interest (Bowling, 2002; Streubert & Carpenter, 1999). Snowball sampling occurs where recruited participants recommend further potential participants with in-depth knowledge of the research subject matter. This method was useful in this study, as the population of interest is well-networked, and it would otherwise have been difficult to identify and access appropriate participants.

Sample size determination is a complex issue in qualitative research and essentially one of breadth versus depth of data, balanced with available resources. Some researchers advocate the idea of continuing data collection until saturation of themes occurs or where no new themes are emerging (Glaser & Strauss, 1967; Strauss & Corbin, 1998; Streubert & Carpenter, 1999). However, others argue that the concept of saturation is flawed because no certainty can be attained that new participants interviewed at a different time would not reveal new themes; thus, the idea of saturation is a myth (Morse, Barrett, Mayan, Olson, & Spiers, 2002; Streubert & Carpenter, 1999). In this study, data collection ceased after ten interviews, when the data had sufficient depth to explore the dimensions of the phenomenon of interest.

Participant Demographics

fn this study, the participants averaged 22.5 years of experience in their respective fields, with some having extensive international experience either through aid organizations or the military. The sample included four environmental health officers, a public health medical officer, public health and environmental health managers, and a disaster management coordinator from both local and state levels of government.

Data Collection and Analysis

In-depth interviews were conducted, using a semi-structured, face- to-face format, interviews lasted between 40 and 60 minutes and were tape recorded and transcribed for analysis. The analysis process proceeded as follows: transcription of interviews; participant validation; preparation of transcriptions for analysis; open, axial, and selective coding, using grounded theory methods described by Strauss and Corbin (1988); and thematic analysis. Ethics

Ethical clearance was obtained from the Queensland University of Technology human research ethics committee and the Queensland health human research ethics committee.

Results and Discussion

The data analysis showed perception of the environmental health role in disaster management as ultimately being a result of the socially constructed meaning of “health,” which is the view people external to public health and environmental health hold. As demonstrated in Figures 2 and 3, two primary processes lead to this occurrence, and the key themes that emerged are described in detail in the following sections. The results also identified a disjuncture between environmental health practitioners and others involved in disaster management about the role of environmental health in disasters.

Relationship of Environmental Health and Public Health

Although most of the participants were working in environmental health, they generally referred to themselves broadly as public health practitioners. This view therefore affects how environmental health practitioners and other disciplines involved in disaster management see the role of environmental health and is important when considering the results, particularly as some debate exists in the literature regarding a need to clarify the distinction between environmental health and public health (Kotchian, 1997; Leggat, 2003).

View of Health

This emerged as the core category, representing how the role of environmental health is defined and also how the role is currently being negotiated. The social construction of “health” and everything represented by “health” in disaster management was found to occur through a complex process of interaction between four concepts: visibility, politics, public perception, and recognition (see Figure 2). The resulting meaning that is attributed to health determines the role of environmental health as those external to the environmental and public health professions perceive it.

The view of health has significant ramifications for the interaction of environmental health in disaster management. People external to public health and environmental health in Queensland view health as both clinical, relating to the observation and treatment of patients; and medical, relating to the practice of medicine through health maintenance or treatment of disease. This view focuses on individual patients. The “alternative” view of health is that health has a dual role: the medical role just described and the role of maintaining the health of the population. These differing views of health result in different outcomes for the role and profile of environmental health.

Participants indicated that if the clinical/medical view was dominant, the public health response to disasters would be neglected in favor of a medical response, which would cause frustration for the environmental health personnel involved. Therefore, a common theme was that the medical view of health that seems to dominate in Queensland has relegated public health and environmental health to second place.

Visibility

The concept of visibility relates to public perception and recognition of the profession. The participants recognized a strong association between the low visibility of the profession and the clinical/medical view of health.

Due to this lack of visibility, participants viewed the environmental health role as lacking significance, often because of its lack of immediately observable or measurable results and the subsequent lack of attention and value attributed to the profession by both the public and government agencies. As such, two ideas strongly related to visibility were public perception and recognition. These concepts have a direct influence on the perception of health, and thus the environmental health role.

Public Perception

Since the public primarily interacts with the medical side of the health system, this shapes their perception of health as relating to the treatment of health-related problems on an individual basis. This leads to a lack of recognition of environmental health, given the public’s influence on political decision making.

Additionally, participants believed that a disconnect existed between environmental health practitioners and the public about environmental health’s role. This was primarily attributed to the terminology that is applied to the profession, with confusion between such concepts as the “health of the environment” and “environmental health.” Berg (2004) sees this misrepresentation as an opportunity for environmental health, due to the increasing emphasis that environmental groups place on human health and the higher profile of these groups, compared to the environmental health field. The advantage, then, is in the opportunity for the environmental health field to state its case to the public and communicate the importance of the field.

Politics

A common theme was that public perception ultimately shapes the political view of health. Therefore, as the medical view dominates the public perception of health, this shapes the focus of provisions by state governments. This relationship between the view of health, public perception, and politics is clearly articulated by one participant: “If the public says you’re not doing enough about health, the Minister [would] be more likely to say ‘Well, more hospital beds,’ or something like that.”

This primacy of the medical view of health translates into lack of recognition of the environmental health role and the subsequent lack of importance ascribed to it. The political conceptualization of health is also inherent in the structures of health organizations, where an unequal distribution of resources favors medical services over public health services.

Recognition

The concept of recognition is strongly tied to visibility and public perception. Participants pointed out that the lack of recognition of environmental health under normal conditions can become exacerbated in disaster situations, despite some recent improvements. If the role of environmental health has not been recognized prior to a disaster, this creates specific problems in relation to disaster response.

Environmental health practitioners with greater experience in disaster management, however, tended to experience less difficulty with being recognized. As such, their interaction in the field had resulted in the renegotiation of their role by others in disaster management. Unfortunately, this recognition did not necessarily translate to all levels of disaster management or benefit all environmental health practitioners advocating for involvement in the field. Disaster management therefore represents a prime area of environmental health activities in which to raise the profile of environmental health, with benefits potentially flowing on into day- to-day activities.

Representation

In the process of renegotiating their role in disaster management, the environmental health profession in Queensland has sought increased representation in the field. The primary way in which participants felt that their profile had been raised was due to increased representation of environmental health and public health on disaster management groups (DMGs) at the local and district levels (see Figure 4). In Queensland, these DMGs are an integral front-line component of the disaster management system and consist of high-level local representatives from key agencies. Under previous long-standing arrangements, however, only medically- orientated personnel were the “health” representatives on these DMGs and thus the environmental and public health role was not highly recognized or valued.

Improved DMG representation, therefore, has provided increased networking and relationship-building opportunities and also has connotations of authority and influence through which environmental health can achieve increased effectiveness in a disaster. In addition, the participants considered the recent process of developing a State Health Emergency Response Plan (SHERP) in Queensland (see Figure 4) to have been integral to a renegotiation of the role of environmental health in disaster management. Again, this was principally through interaction with a number of agencies involved in disaster management, resulting in a higher public health profile. It is then through this process that the importance of the “alternative” view of health, encompassing both medical and public health, is able to be emphasized.

Conclusion

This study explored the role of environmental health in disaster management and how environmental health practitioners and others involved in disaster management perceive this role in Australia, and particularly in Queensland. The study found that the environmental health role in disaster management is primarily a result of the socially constructed view of health. The traditional “medical” view of health has resulted from a complex interplay of the concepts of visibility, public perception, politics, and recognition. As a result of this view of health, public health, inclusive of environmental health, has been relegated to second place behind medical health services within disaster management. Environmental health in particular has therefore had a very low profile.

In Queensland, representation on DMGs and the SHERP process have improved the profile of environmental health practitioners and environmental health in general. With representation on local and district DMGs, the value of environmental health is being increasingly recognized. Authority and influence also come with DMG representation, due to the development of relationships with those in charge of coordinating disaster response efforts. Ultimately, the heightened environmental health profile and increasing recognition by others involved in disaster management will result in a more effective and appropriate response to disaster situations. The results of this study highlight how disaster management has provided an opportunity for the environmental health profession to raise its profile and renegotiate the role of environmental health in disaster management. The results also demonstrate how the benefits of a higher profile, greater recognition, and representation in the disaster management arena can carry over to normal day-to-day activities. Environmental health practitioners are therefore encouraged to have greater involvement in disaster management, as this provides opportunities to develop relationships with high- level personnel from other agencies, leading to role renegotiation and the ascribing of importance to the role played by environmental health in both disaster and non-disaster situations.

REFERENCES

Abrahams, J. (2001). Disaster management in Australia: The national emergency management system. Emergency Medicine Australasia, 13, 165-173.

Armstrong, E (2003). Alert but not alarmed: Australia’s health system prepares. Australian Nursing Journal, 10, 22-24.

Bashir, Z., Lafronza, V., Fraser, M.R., Brown, C.K., & Cope, J.R. (2003). Local and state collaboration for effective preparedness planning. Journal of Public Health Management and Practice, 9, 344- 351.

Berg, R. (2004). Terrorism response and the environmental health role: The million-dollar (and some) question. Journal of Environmental Health, 67(2), 29-39.

Bowling, A. (2002). Research methods in health: Investigating health and health services (2nd ed., pp. 187-188). Buckingham, UK: Open University Press.

Bradt, D.A., Abraham, K., & Franks, R. (2003). A strategic plan for disaster medicine in Australasia. Emergency Medicine Australasia, 15, 271-282.

Brimblecombe, P. (2003). Historical perspectives on health: The emergence of the sanitary inspector in Victorian Britain. Journal of the Royal Society for the Promotion of Health, 123, 124-131.

Burkle, F.M. (2006). Globalization and disasters: Issues of public health, state capacity, and political action. Journal of International Affairs, 59, 241-265.

Caldicott, D.G.E., & Edwards, N.A. (2002). The global threat of terrorism and its impact on Australia. Emergency Medicine Australasia, 14, 218-229.

Chenitz, W.C., & Swanson, J.M. (1986). From practice to grounded theory: Qualitative research in nursing (p.7). Menlo Park, CA: Addison Wesley.

Crotty M. (1998). The foundations of social research: Meaning and perspective in the research process (p. 78). St. Leonards, Australia: Allen and Unwin.

Emergency Management Australia. (2003). Mapping the way forward for large-scale urban disaster management in Australia: Building on the lessons from September 11, 2001. Retrieved April 13, 2005, from http://www.ema.gov.au/agd/EMA/rwpattach.nsf/VAP/ (63F2fBC6A4528BAE4CED2F9930C45677)~EMALessonsLearntbookletfinal.pdf/ $file/EMALessonsLearntbookletfinal.pdf

Emergency Management Australia. (2005). Concepts and principles in emergency management. Retrieved May 31, 2005, from http:// www.ema.gov.au/agd/EMA/emaInternet.nsf/Page/

ions_Menu_Principles_Concepts_and_Principles_Concepts_and_Principles

Fabian, N. (2002). Post September 11: Some reflections on the role of environmental health in terrorism response. Journal of Environmental Health, 64(9), 78, 77, 65.

Fabian, N. (2004). It can be done-making the invisible visible. Journal of Environmental Health, 67(2), 70, 51.

Fisher, D., & Burrow, J. (2003). The Bali bombings of 12 October, 2002: Lessons in disaster management for physicians. Internal Medicine Journal, 33, 125-126.

Forsting, S.L. (2004). Environmental health professionals and emergency preparedness: Canadian perspectives. Journal of Environmental Health, 67(4), 31-35.

Gergen, K.J. (2003). Knowledge as socially constructed. In M. Gergen & K.J. Gergen (Eds.), Social construction: A reader (pp. 1- 10). London: Sage Publications.

Glaser, B.G., & Strauss, A.L. (1967). The discovery of grounded theory: Strategies for qualitative research (pp. 61-62). New York: Aldine De Gruyter.

Khan, A.S., Morse, S., & Lillibridge, S.R. (2000). Public-health preparedness for biological terrorism in the USA. Lancet, 356, 1179- 1182.

Kotchian, S.B. (1993). Environmental leadership in a public health agency. Journal of Environmental Health, 55(5), 60-61.

Kotchian, S.B. (1997). Perspectives on the place of environmental health and protection in public health and public health agencies. Annual Review of Public Health, 18, 245-259.

Leggat, P (2003). Environmental health: Global initiatives and new analytical approaches. Journal of Rural and Remote Environmental Health, 2(2), 36-37.

Liamputtong, P., & Ezzy D. (2005). Qualitative research methods (2nd ed., pp. 265-267). Melbourne: Oxford University Press.

Loeb, M. (2004). Severe acute respiratory syndrome: Preparedness, management and impact. Infection Control and Hospital Epidemiology, 25, 1017-1019.

Logue, J.N. (1996). Disasters, the environment, and public health: Improving our response. American Journal of Public Health, 86, 1207-1210.

Lurle, N., Wasserman, J., & Nelson, CD. (2006). Public health preparedness: Evolution or revolution? Health Affairs, 25, 935-945.

Lyman, F. (2003). Messages in the dust: Lessons learned, post-9/ 11, for environmental health. Journal of Environmental Health 66(5), 31.

Morse, J.M., Barrett, M., Mayan, M., Olson, K. & Spiers, J. (2002). Verification strategies for establishing reliability and validity in qualitative research. International Journal of Qualitative Methods, 1(2), Article 2. Retrieved April 19, 2005, from http://www.ualberta.ca/~ijqm/

Noji, E.K. (2001). Bioterrorism: A new global environmental health threat. Global Change Human Health, 2, 46-53.

Noji, E.K. (2005). Public health in the aftermath of disasters. British Medical Journal, 330, 1379-1381.

Noji, E.K., & Toole, M.J. (1997). The historical development of public health responses to disasters. Disasters, 21, 366-376.

Rasmussen, J., & Jensen, S. (1998). Incident management systems: A means of enhancing coordination, communication and decision making in a disaster. National Emergency Management, 13(3), 13-15, 17-18.

Roberts, R. (1996). EHOs do have ancestors! Journal of Environmental Health, 59(5), 20.

Srinivasan, A., McDonald, L.C., Jernigan, D., Helfand, R., Ginsheimer, K., Jernigan, J., Chiarello, L., Chinn, R., Parashar, U., Anderson, L., Cardo, D., & SARS Healthcare Preparedness and Response Plan Team. (2004). Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infection Control and Hospital Epidemiology, 25, 1020- 1025.

Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Grounded theory procedures and techniques (2nd ed.). Thousand Oaks, CA: Sage Publications.

Streubert, H.J., & Carpenter, D.R. (1999). Qualitative research in nursing: Advancing the humanistic perspective (2nd ed.) Philadelphia: Lippincott.

Vinen, J. (2003). Bali: A wake-up call. Internal Medicine Journal, 33(3), 71-73.

Deanna Eldridge

Thomas D. Tenkate, Dr.P.H.

Corresponding Author: Thomas D. Tenkate, Senior Lecturer in Environmental Health, QUT School of Public Health, Victoria Park Road, Kelvin Grove, QLD, Australia 4059. E-mail: [email protected].

Copyright National Environmental Health Association Sep 2008

(c) 2008 Journal of Environmental Health. Provided by ProQuest LLC. All rights Reserved.

State Faults Hospitals in Probe of Workers’ Bogus CPR Cards

By Tania Chatila

The California Department of Public Health has concluded an investigation into the possession of fake cardiopulmonary resuscitation cards by workers at Citrus Valley Medical Center.

According to a report released this week, the department found the facility failed to ensure conditions of employment were completed, and the facility failed to report the incident in a timely manner.

Fifty-nine employees throughout the health care provider’s four San Gabriel Valley campuses resigned or were fired over in late August and early September in connection with the fraudulent cards.

The investigation was prompted by an instructor who noticed her name spelled wrong on the back of one of the fake cards, officials said.

Of the former employees, 26 nurses were reported to the California Board of Registered Nursing.

In addition, 11 certified nurse assistants were reported to the state Department of Public Health, seven respiratory care practitioners were reported to the Respiratory Care Board of California, and two licensed vocational nurses were reported to the Board of Licensed Vocational Nurses and Psychiatric Technicians.

The remaining 13 employees did not require licenses.

Citrus Valley Health Partners is made up of 3,200 employees spread across four campuses: Citrus Valley Medical Center’s Inter- Community Campus in Covina, Queen of the Valley Campus in West Covina, Foothill Presbyterian in Glendora and Citrus Valley Hospice, a hospice/home health agency in West Covina.

(c) 2008 San Gabriel Valley Tribune. Provided by ProQuest LLC. All rights Reserved.

Midland Hospitals Cancel Operations Over Winter Bug Outbreak

By Emma Brady

Two Midland hospitals have cancelled all non-emergency operations for today and tomorrow, and 15 wards remain closed across the region as patients recover from an outbreak of the winter vomiting bug, norovirus, yesterday.

Worcestershire Acute Hospitals NHS Trust – which runs the Alexandra Hospital in Redditch, Royal Worcestershire in Worcester, and Kidderminster Hospital – remains the worst hit, with 120 patients on 14 wards still suffering from diarrhoea and vomiting.

Ward D11 at City Hospital, in Winson Green, Birmingham, also remains closed to new admissions as eight patients are still displaying symptoms, which usually last for 48 hours. Four patients at Warwick Hospital have also been diagnosed with the bug, but no wards have been closed as yet. The Alexandra Hospital and Worcestershire Royal Hospital have seen a “steady increase” in the number of people with diarrhoea and vomiting.

John Rostill, the trust’s chief executive, said: “We strongly advise people to think twice before visiting family and friends and to do so only if it is essential.

“If they have to visit then they will need to wash their hands with soap and water as they enter and leave the ward and also use the hand gel.

“Using the hand alcohol rub on its own is not sufficient to kill these particular germs.”

Norovirus is prevalent in the community and anyone who has been in contact with family or friends suffering from diarrhoea or vomiting in the past 48 hours should not visit already vulnerable hospital patients.

A spokesman for Sandwell and West Birmingham Hospitals NHS Trust, which runs City Hospital, added: “We have an aggressive policy for dealing with norovirus, which means we act immediately to close the affected ward and stop all visitors and non essential staff entering the ward when patients exhibit any common norovirus symptoms.”

All visiting was suspended at most of Warwick Hospital yesterday, but one visitor per patient is still permitted at the intensive care unit, MacGregor children’s unit, Swan maternity ward and the coronary care unit.

[email protected]

(c) 2008 Birmingham Post; Birmingham (UK). Provided by ProQuest LLC. All rights Reserved.

Hillsdale College Free Market Forum Schedule Announced

HILLSDALE, Mich., Sept. 25 /PRNewswire-USNewswire/ — Hillsdale College announced the final schedule for Hillsdale College Free Market Forum being held in Dearborn, Michigan from September 25-27, 2008. The topic of the Forum is “The Role of Markets and Governments in Pursuing the Common Good” and will be held at The Dearborn Inn located at 20301 Oakwood Boulevard in Dearborn, MI.

   The complete schedule for the Forum is below.    Note: The following events will be held at The Dearborn Inn.    Thursday, September 25    8:00 pm     "Economics and the 2008 Election"               Karl Rove               FOX News Commentator   Friday, September 26    8:00 am     Panel #1: "Markets and Politics"               Chair:  Gary Wolfram               Hillsdale College                "The Politics of Healthcare"               Kimberley Strassel               Wall Street Journal                "Taxes & Deficits - a 2008 Perspective"               Alan Reynolds               CATO                "Energy Dependency and the Role of Government"               Fran Smith               Competitive Enterprise Institute    10:15 am    Panel #2:   "Freedom and the Environment"               Chair:  Jay Richards               Acton Institute                "The Problem with Environmental Education Today"               Michael Sanera               John Locke Foundation                "The Use and Abuse of Global Warming"               Steven Hayward               American Enterprise Institute                "Endangered Species: The Case of the Polar Bear"               Ben Lieberman               Heritage Foundation    1:30 pm     Panel #3: "21st Century Challenges to Property Rights"               Chair:  William H. Mellor               Institute for Justice                "History of Property Rights               James Ely, Jr.               Vanderbilt University                "Property Rights after KELO"               Edward J. Erler               California State University, San Bernardino                "Water Rights: Current Controversies"               Gary Libecap               University of California Santa Barbara     8:00 pm     "The Theoretical Roots of American Bureaucracy"               Jonah Goldberg               Author, Liberal Fascism: The Secret History of the American               Left, From Mussolini to the Politics of Meaning   Saturday, September 27    8:00 am     Panel #4:  "Is Free Trade Fair Trade?"               Chair:  Burton Folsom               Hillsdale College                Discussant: Don Boudreaux               George Mason University                "The Development of Free Trade in Europe"               Gene King               Oklahoma Baptist University                "Free Trade as an Instrument of Justice"               John E. Charalambakis               Asbury College                "The Morality of Free Trade"               J. Stephen Phillips               Belhaven College    10:15 am    "How to Teach Economics"               Ken Elzinga               University of Virginia  

Note: The following event will be held at the Ford Event & Conference Center, located directly across from the Ford Museum.

   8:00 pm     "Property Rights and a Free Society"               Hernando De Soto               Institute for Liberty and Democracy  

Hillsdale College

CONTACT: Chris Bachelderm of Hillsdale College, +1-517-607-2307,[email protected]

Web Site: http://www.hillsdale.edu/

Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix

CHICAGO, Sept. 25 /PRNewswire/ — Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced today that it has completed its agreement with Gentiva Health Services, Inc. to acquire a controlling interest in CareCentrix. The firm also announced that it has recruited Eric Reimer to serve as chief executive officer of CareCentrix, and Steve Shulman and Steve Cosler to join the board of directors. Together, they will focus on repositioning and expanding CareCentrix, the nation’s largest coordinator of home health care services for managed care organizations.

Eric Reimer, 39, most recently led strategic development for Magellan Health Services, Inc. . He spearheaded the company’s acquisition of National Imaging Associates, where he assumed the CEO position and transformed the $50 million business into a full-service radiology benefits management firm, generating $300 million in annualized revenue. Mr. Reimer also was instrumental in Magellan’s acquisition of ICORE Healthcare, a specialty pharmaceutical business. During his five years with Magellan, Mr. Reimer managed and collaborated with the nation’s largest health care plans. Prior to Magellan, Mr. Reimer held executive positions with CIGNA Health Services and Prudential Healthcare. He also worked with Boston Consulting Group, after receiving his master’s degree in business administration from the Wharton School of the University of Pennsylvania.

“Water Street has focused on finding platforms in specialty benefits management since we identified payer services as an attractive investment segment three years ago,” said Ned Villers, a partner with Water Street and leader of the firm’s payer services initiative. “During this time, we’ve met with many impressive executives, but Eric stands out as an exceptional leader and the perfect fit for CareCentrix. His direct experience, strategic insight and strong track record of building market-leadership companies make him the ideal CEO for CareCentrix. We are confident that Eric will help the company execute the many growth opportunities that exist in home health care.”

Established in 1996, CareCentrix manages home nursing, infusion and medical equipment services for more than 10 million people across the country through a network of 4,000 credentialed home care providers. With the average cost of a home health care visit substantially less than the daily cost of care received in a hospital or skilled nursing facility, home health care has the potential to save patients and payers millions of dollars on an annual basis. The multi-billion dollar industry is projected to experience significant growth over the next 10 years, as U.S. demographics continue to shift to an older population and pressure to reduce health care costs intensifies.

“I am very excited to join CareCentrix at this important point in the company’s and industry’s evolution,” said Reimer. “The CareCentrix team has done an outstanding job of building the nation’s most comprehensive home health care management program. The company is now ideally positioned to support managed care organizations that are increasingly searching for new ways to manage costs. Our intention is to build on CareCentrix’s strong foundation to transform it into a strategic leader that is proactively helping payers reduce their overall medical spend and achieve better patient outcomes.”

Steve Shulman and Steve Cosler Join Board of Directors

To support CareCentrix’s plans for expansion, Water Street has recruited Steve Shulman and Steve Cosler to serve on the board of directors.

A highly regarded leader in the health care industry, Mr. Shulman is perhaps best known for leading Magellan’s successful turnaround from bankruptcy to the nation’s foremost specialty health care management company. He also led Prudential Healthcare through a major transformation, culminating in its sale to Aetna, while serving as the company’s chairman, president and CEO. Joining Mr. Shulman on the board is Steve Cosler, who is an operating partner with Water Street and the former CEO of Priority Healthcare, a leading specialty pharmacy company. Executives from Gentiva Health Services and Water Street also will serve on the board.

“We have assembled an exceptional group of leaders with unparalleled expertise in payer services to serve on the board of CareCentrix,” said Villers. “Their collective experience and industry network will be invaluable to CareCentrix’s management team, as we expand the company’s value proposition and pursue new relationships with the nation’s largest payers.”

About CareCentrix

CareCentrix is the nation’s largest coordinator of home health care services for managed care organizations. The company manages home nursing, infusion and medical equipment services for more than 10 million members of managed care organizations across the country through a network of 4,000 credentialed home care providers. Established in 1996, CareCentrix is headquartered in Hartford, Connecticut. For more information about CareCentrix, visit http://www.carecentrix.com/.

About Water Street Healthcare Partners

Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. The firm has a strong track record of building market-leadership companies across key growth sectors in health care. It has partnered with some of the world’s leading health care companies on its investments, including: Johnson & Johnson, Medtronic and Smith & Nephew. Water Street’s team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses. The firm is headquartered in Chicago. For more information about Water Street, visit http://www.wshp.com/.

Water Street Healthcare Partners

CONTACT: Kelly Zitlow of Water Street Healthcare Partners,+1-847-858-5230, [email protected]

Web site: http://www.wshp.com/http://www.carecentrix.com/

Arthrosurface(R) HemiCAP(R) Toe Resurfacing Implant Receives Reimbursement Approval From Major Insurance Carriers

FRANKLIN, Mass., Sept. 25 /PRNewswire/ — Arthrosurface, Inc. (http://www.arthrosurface.com/), the developer of less-invasive joint resurfacing systems, announced that its HemiCAP(R) toe hemiarthroplasty product is now approved for reimbursement by Aetna and other major insurance carriers.

“We are very pleased that Aetna has responded to surgeon and patient requests, as well as our own appeal submission, to review and update their coverage policy for these patients that have been facing difficult treatment decisions. We will continue to review coverage policy with several other insurance carriers that have referenced Aetna’s previous position in their own coverage policy statements,” commented Steven Ek, COO.

Metatarsal head resurfacing with the HemiCAP(R) implant provides a modern treatment approach for patients with Grade II and early Grade III MTP changes. This intermediate patient population can be served with a motion-preserving surgical alternative for providing pain relief and functional improvement.

The metatarsal phalangeal joint or great toe is considered one of the most common osteoarthritic joints and the often painful condition of hallux rigidus is reported to be present in females at a rate of 2:1 over males. The underlying disease process of hallux rigidus is not fully understood but it is believed to be associated with joint impingement diseases and previous traumas such as sports or occupational injuries.

Arthrosurface is a medical device manufacturer specializing in the development of cartilage resurfacing systems targeted for the middle aged and active patient. The company’s systems are indicated and FDA cleared for use in the knee, shoulder, hip and toe.

Arthrosurface, Inc.

CONTACT: Anthony C. Moretti, CFO of Arthrosurface, Inc.,+1-508-520-3003

Web site: http://arthrosurface.com/

Physician Offers Innovative Primary Health Care Services to Provo Area Patients

PROVO, Utah, Sept. 25 /PRNewswire/ — Wesley D. Wylie, M.D., will open a new primary care practice designed to appeal to patients in search of a user- friendly alternative to the long wait times, rushed appointments and lack of personal interaction that most patients experience with their doctors.

The latest of several ModernMed practices nationwide, Dr. Wylie will serve patients in the Provo area and is scheduled to open on Nov. 17. The practice will accommodate a maximum of only 350 patients, compared to the 2,500 patient load of the average primary medical practice.

Concierge medicine is gaining popularity across the nation as a growing number of Americans report dissatisfaction with current health care services. Studies have shown that adults in the U.S. report lower levels of satisfaction with their health care compared to residents of similar countries like the U.K. and Canada.

“The current model of medicine is designed to treat illness once it surfaces,” explains Dr. Wylie.

“By far, the majority of current health issues are a direct result of poor preventative measures. My new practice allows me to give each of my patients the time and attention they deserve and design an individual health plan for each patient that allows for optimal wellness. The goal is prevention and, by being proactive, we can prevent many diseases and illnesses.”

The distinguishing characteristic of the practice is the extraordinary level of access to Dr. Wylie and his staff. Regular office hours will be Monday through Friday from 9:30 a.m. to 6:30 p.m. and, in addition to guaranteed same-day or next-day appointments, Dr. Wylie will make house calls as needed to help those with limited access to care. Patients can also contact him 24/7 through email or mobile phone.

Dr. Wylie will treat pediatric and adult patients with a broad range of homeopathic and wellness services to complement his preventive approach to primary health care. Fully trained in critical care, obstetrics, gynecology, newborn and pediatric care, Dr. Wylie diagnoses and manages a wide array of medical issues including diabetes, heart disease, rheumatologic, psychiatric and acute care needs. Patients will receive annual comprehensive wellness exams and have direct access to their electronic medical records.

A graduate of the University of Texas Medical School, Dr. Wylie is board- certified by the American Academy of Family Practice. He completed his residency at the Memorial Health Care Systems in Houston and treated patients from around the globe at the renowned Texas Medical Center, known worldwide for its hospitals and research.

He is an instructor at the University of Utah Medical School and has served on the board of directors for Utah Valley Physicians Network and as vice chairman of the Department of Family Practice at Mountain View Hospital in Payson, Utah.

Dr. Wesley D. Wylie is a member of ModernMed’s forward-thinking primary health care service firm, focused on providing a revolutionary health care experience unlike any traditional medical practice. For more information about Dr. Wylie, please visit http://www.modernmed.com/wylie or call 1-866-603-6777.

ModernMed, Inc.

CONTACT: Eve Schremp, Senior Vice President, ModernMed, Inc.,+1-480-502-6777

Web site: http://www.modernmed.com/wylie

TrackPower Name Change Effective

TORONTO, Sept. 25 /PRNewswire-FirstCall/ — TrackPower, Inc. (OTCBB: TPWR) announced today the completion of its merger with its wholly owned subsidiary, Gate to Wire Solutions, Inc. (“G2W”). As a result of this merger, the Company’s name has become “Gate to Wire Solutions, Inc.,” effective at market opening, Friday, September 26, 2008. The Company’s new trading symbol for its Common Stock shall become “GWIR” on the effective date. Also as a result of the merger, each one hundred (100) outstanding shares of the Company’s common stock has been converted into one (1) fully paid and non-assessable share of the Common Stock of G2W.

“This was a significant and necessary restructuring step that we believe is in the best interests of the Company,” said John Simmonds, Chairman and CEO of G2W today. “There are exceptional opportunities in Latin America and it was necessary to restructure and reposition the Company to take advantage of them. We have put together an amazing team and we expect to make some exciting announcements about the direction of the Company in that region.”

G2W, now a Nevada corporation, is a comprehensive service provider and advisory organization to horse racing and pari-mutuel wagering interests in Latin America, comprised of seasoned industry executives whose combined experience is being re-focused on the Latin American horse racing industry.

The Company intends to improve upon and further develop the horse racing industry in Latin America through the deployment of modern technology, North American experience and sound operational methodologies. By focusing a team of industry professionals who possess decades of experience in horse ownership, breeding, racing and racetrack operations, management believes G2W has the ability to develop and implement upgrades to client facilities aimed at maximizing revenue and patron experience, providing scalable, turnkey solutions to existing operations, and/or innovative and efficient, state-of-the-art solutions to new enterprises.

Forward-Looking Statements

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 — With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of G2W could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company’s operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as “may,””will,””should,””expect,””plan,””anticipate,””believe,””estimate,””predict,””potential” or “continue,” the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors see the risk factors associated with our Company, included in our SEC filings.

TrackPower, Inc.

CONTACT: please visit http://www.g2wsolutions/, or contact: Gate to WireSolutions, Inc., John Simmonds, Chairman and CEO, (905) 833-9845 ext. 223,(905) 844-9847 (FAX), [email protected]

A Bitter Pill for Cancer Patients

By Matthew McCreary

NORTHERN Ireland’s Executive has been urged to “get on with it” to ensure cancer sufferers in Northern Ireland are not left out in the cold over prescription charges.

Yesterday’s decision from Prime Minister Gordon Brown that drugs charges for cancer patients in England are to be abolished means Northern Ireland is now the only area of the UK which has not announced that the fees for cancer patients will be scrapped.

The Prime Minister’s plans will not extend to Northern Ireland without the agreement of the Stormont Assembly, which is currently deadlocked amid political in-fighting and whose executive has not met in several months.

Deputy SDLP leader and south Belfast GP Dr Alasdair McDonnell, who was in Manchester for the PM’s speech yesterday, said: “I believe that this is a good announcement.

“I would urge the Health Minister to bring this forward in Northern Ireland as soon as possible.”

“I would urge the Executive to get on with it.

“People suffering from cancer are usually short of funds and this is a small gesture in the right direction to make their life a little easier.

“I think the onus now is to urge the Executive to get on with this. If Gordon Brown can do it then we should be able to do it in Northern Ireland.”

Alliance Party leader David Ford said: “It’s a further example of action that could be taken in Northern Ireland if the Executive would get its act together, alongside the fuel crisis and other issues which affect people’s lives.

“The Executive must meet and start taking decisions.”

Heather Monteverde from charity Macmillan Cancer Support in Northern Ireland welcomed the decision to drop charges for people with cancer in England, but said: “Unfortunately this leaves Northern Ireland behind, as Wales scrapped charges for everyone last April and Scotland is in the process of phasing them out.

“On taking office last May, Health Minister Michael McGimpsey promised to review the situation and there has since been a consultation.”

“What we need is action from the Minister to bring Northern Ireland into line with the other regions. We want to see prescription charges dropped for cancer patients here too. It is morally wrong for patients in Northern Ireland – and there are more than 50,000 people living with cancer here – to pay for their prescriptions when the rest of UK don’t have to.”

Last year the Belfast Telegraph launched the ‘Prescriptions: Free For All’ campaign, calling for charges to be scrapped by the Assembly.

Health Minister Michael McGimpsey said last night: “I requested a review into the abolition of prescription charges in Northern Ireland because of the serious inequities and weaknesses in the current system that need to be addressed.

“It is deeply concerning to hear prescription charges deter some people from having their prescriptions dispensed, either in part or entirely. The long term costs for the Health Service would improve if patients were able to afford the medication to treat their condition.

“I have received the report from the review group, and am currently considering options for the future of prescription charges.”

(c) 2008 Belfast Telegraph. Provided by ProQuest LLC. All rights Reserved.

Industry Data Shows Hollywood Paid Actors To Endorse Smoking

Newly released industry documents show tobacco firms paid huge amounts for endorsements from the stars of Hollywood’s “Golden Age”.

The documents, released following anti-smoking lawsuits, reveal the extent of the relationship between tobacco and movie studios””one firm paid more than $3m in today’s money in one year to stars.

Classic films of the 1930s, 1940s and 1950s still helped promote smoking today, according to researchers writing in the Tobacco Control journal.

Researchers at the University of California at San Francisco said virtually all of the biggest names of the 1930s, 1940s and 1950s were involved in paid cigarette promotion.

They obtained endorsement contracts signed at the times to help them calculate just how much money was involved.

Stars prepared to endorse tobacco included Clark Gable, Cary Grant, Spencer Tracy, Joan Crawford, John Wayne, Bette Davis and Betty Grable, researchers said.

Deals dated from the start of the “talkie” era, with “Jazz Singer” star Al Jolson signing testimonials stating that the “Lucky Strike” brand was “the cigarette of the acting profession”.

“The good old flavor of Luckies is as sweet and soothing as the best ‘Mammy’ song ever written,” he wrote.

Researchers uncovered a list of payments for a single year in the late 1930s detailing how much American Tobacco, the makers of Lucky Strike, paid certain stars.

Leading ladies Carole Lombard, Barbara Stanwyck and Myrna Loy were handed $10,000, equivalent to just under $150,000 in today’s money, to endorse the brand, as were Clark Gable, Gary Cooper and Robert Taylor.

The annual price of paying actors all together was $3.2m in 2008 terms.

Tobacco firms would, in some cases, pay movie studios to create radio shows that featured their stars’ endorsements.

American Tobacco paid Warner Brothers the equivalent of $13.7m for 1937’s “Your Hollywood Parade”, and sponsored The Jack Benny Show from the mid-1940s to the mid-1950s””featuring stars such as Lauren Bacall giving carefully scripted testimonials.

Lead researcher Professor Stanton Glantz, said that the effects of the millions poured into Hollywood by “Big Tobacco” could still be felt today, despite a recent self-imposed ban on promotion within films.

Smoking imagery in films can influence younger people to start smoking, researchers say.

“As in the 1930s, nothing today prevents the global tobacco industry from influencing the film industry in any number of ways,” the report said.

“Classic” films with smoking scenes, such as “Casablanca” and “Now, Voyager”, and glamorous publicity images helped to “perpetuate public tolerance” of on-screen smoking, they said.

While smoking imagery could not be “outlawed completely”, there is an argument for clearer warnings before films, according to UK anti-smoking group ASH.

——

Image Courtesy Of Google

——

On The Net:

University of California, San Francisco


Tobacco Control

ASH

Washington Redskins Open FedExField Locker Room to the Public for Free Prostate Health Screenings

To: HEALTH EDITORS

Contact: Scott Shepherd of Washington Redskins, +1-703-726-7417; Scott Williams of Men’s Health Network, +1-202-543-6461 Ext. 101; or Jeff Heckelman, Edelman, +1-212-642-7718, for Men’s Health Network

Fans given players’ access to FedExField after prostate health screenings

WASHINGTON, Sept. 25 /PRNewswire-USNewswire/ — The following was released today by the Men’s Health Network:

WHAT:In recognition of September as Prostate Health Awareness Month, the Washington Redskins, GlaxoSmithKline, Men’s Health Network, American Urological Association Foundation, and the Prostate Cancer Education Council are carrying out a unique screening event in the locker rooms at FedExField to encourage men to be proactive about their prostate health. Participating men will receive free prostate specific antigen (PSA) tests, digital rectal exams (DRE), and patient information on prostate health in the Redskins locker room. Participants will also be able to tour the stadium and get a “players view” of FedExField.

WHO:Men, ages 40+

WHEN:Saturday, September 27, 10 a.m. – 3 p.m.

WHERE:Redskins Locker Room, FedExField, Landover, MD

WHY:

-50% of men over 50 have an Enlarging Prostate

– Prostate Cancer affects 1 out of every 6 men in the United States

– 186,320 men are estimated to be diagnosed with prostate cancer in 2008

– An annual prostate health exam and screening can diagnose both of these serious medical conditions, which if diagnosed early, are more readily treatable

PLEASE NOTE:All attendees are requested to register prior to the event to obtain proper credentials.

SOURCE Men’s Health Network

(c) 2008 U.S. Newswire. Provided by ProQuest LLC. All rights Reserved.

Wellmark Blue Cross and Blue Shield First in Nation to Measure Well-Being of Health Plan Members, Employees

Wellmark Blue Cross and Blue Shield, headquartered in Des Moines, IA and doing business in Iowa and South Dakota, is the first employer and health plan in the United States to engage in a well-being analysis of both its employees and plan members using the Gallup-Healthways Well-Being Index.

Healthways, Inc. (NASDAQ: HWAY) and Gallup today announced the results of analysis from the Index, which was introduced in January and shows that improved employee health and engagement lead to better individual and business performance.

Wellmark will be able to utilize the survey findings to identify opportunities to enhance the well-being of its customers and employees, thereby improving individual, family, employer, and community performance.

“We commend Wellmark for taking this initiative and for its efforts to improve the well-being of its members and employees. True leaders create change, and Wellmark has demonstrated its market leadership through its continuing commitment to health and well-being as an employer and on behalf of its members,” said Ben Leedle, Jr., President and CEO, Healthways.

Wellmark results, which were compiled between July 28 and August 17, 2008, and included a survey sample of 1,465 members and employees, exceeded national and state benchmarks for both groups. When asked to rate their overall well-being on a scale of 1 – 10, Wellmark members averaged 8.20, while employees averaged 7.97 compared to the national benchmark of 7.11 and the Iowa and South Dakota benchmarks of 7.21 and 7.07, respectively.

When asked to describe their current health status, more than 80 percent of members and employees described their health as good, very good or excellent which is indicative of Wellmark’s history of being a pioneer in the provision of innovative programs for its customers.

“This is a crucial metric because all good things happen in the presence of high well-being,” said Gallup Chairman and CEO Jim Clifton. “Our mission is to create new official statistics for leaders that report the state of employees’ health and well-being and to create solutions to transform and improve not only the work environment but also employees’ lives.”

Additional findings:

— Ninety percent of the Wellmark employees indicated a high degree of cultural support for well-being in their workplace as compared to 40% of Wellmark members indicating cultural support in their places of employment.

— Individuals who are suffering or struggling have a tendency to have higher disease burden and more physical limitations. Improving the physical and emotional health of these individuals increases their overall well-being score.

— Irrespective of disease status, individuals who are thriving will continue to do so as long as they can maintain their well-being and engage in behaviors to maintain their health.

— Individuals in a high negative work environment indicate that their job impacts their health and these individuals are also more likely to be disengaged at work.

“Continuously improving the health and well-being of our members and the communities we serve is a key component of the Wellmark vision,” said John D. Forsyth, Chairman and CEO, Wellmark. “The Gallup-Healthways Well-Being Index data will allow us to better meet the specific needs of our members and employees and realize our vision.”

“Wellmark took an important first step in conducting this survey to set internal benchmarks for its members and its employees. They have seen the value of adding the new data provided by the Well-Being Index to create a full picture of the needs of its customers and employees. The on-going evaluative nature of the Well-Being Index will provide continuing insights and data to health plans, governments, communities and employers to continuously measure the effects of their efforts to improve the health and well-being of their population,” Leedle concluded.

The Gallup-Healthways Well-Being Index is the first and largest survey of its kind, with 1,000 completed surveys a day, seven days a week for 25 years. The Index is a daily measure determining the correlation between the places where people work and the communities in which they live, and how these and other factors impact well-being. Additionally, the survey data that makes up the Index will increase the understanding of how these factors impact the financial health of corporations and communities.

Health plans, employers, government, and individuals now have new data upon which to evaluate the impact of current programs and support the development of future services. The Gallup-Healthways Well-Being Index provides non-traditional data that enables sponsors to better understand additional and critical factors that have been shown to have an important effect on health, its cost and productivity impact. There are six contributors to overall well-being of which health (physical and emotional) and work environment are major factors.

About Wellmark

Wellmark, Inc. (www.wellmark.com) does business as Wellmark Blue Cross and Blue Shield of Iowa. Wellmark and its subsidiaries and affiliated companies, including Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc., insure or pay health benefit claims for more than two million members in Iowa and South Dakota. Wellmark Blue Cross and Blue Shield of Iowa, Wellmark Blue Cross and Blue Shield of South Dakota, and Wellmark Health Plan of Iowa, Inc. are independent licensees of the Blue Cross and Blue Shield Association.

About Healthways

Healthways, Inc. is the leading provider of specialized, comprehensive Health and Care Support(SM) solutions to help millions of people maintain or improve their health and, as a result, reduce overall healthcare costs. Healthways’ solutions are designed to help healthy individuals stay healthy, mitigate and slow the progression of disease associated with family or lifestyle risk factors and promote the best possible health for those already affected by disease. Our proven, evidence-based programs provide highly specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, internet and face-to-face interactions, both domestically and internationally. Healthways also provides a national, fully accredited complementary and alternative Health Provider Network, offering convenient access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system. For more information, please visit www.healthways.com.

About Gallup

Gallup has studied human nature and behavior for more than 70 years. Gallup’s reputation for delivering relevant, timely, and visionary research on what people around the world think and feel is the cornerstone of the organization. Gallup employs many of the world’s leading scientists in management, economics, psychology, and sociology, and our consultants assist leaders in identifying and monitoring behavioral economic indicators worldwide. Gallup consultants also help organizations boost organic growth by increasing customer engagement and maximizing employee productivity through measurement tools, coursework, and strategic advisory services. Gallup’s 2,000 professionals deliver services at client organizations, through the Web, at Gallup University’s campuses, and in 40 offices around the world. For more information go to www.gallup.com.

PolyMedix Initiates Dosing in Phase I Study of Anticoagulant Compound

PolyMedix, a biotechnology company, has initiated dosing and commenced a Phase I clinical study in the US with its anticoagulant reversing agent PMX-60056 under an investigational new drug application filed with the FDA.

This first Phase I clinical trial will assess the safety of PMX-60056. The protocol for this study involves a dose-escalation study in healthy volunteers in which each subject will receive a single dose of PMX-60056. The subjects are grouped into different cohorts with different dosage levels which will allow for the study of the effects of increased dosages.

If the first clinical study is successfully completed, PolyMedix plans to initiate a second clinical trial as a proof of concept study to evaluate both safety and efficacy of PMX-60056. The second clinical trial, also to be conducted in healthy volunteers, will involve first administering heparin to subjects, and then afterwards administering a single dose of PMX-60056.

This study will assess both the safety of using PMX-60056 in heparinized subjects, and will also measure the ability of PMX-60056 to neutralize heparin and normalize blood clotting time. Following these clinical trials, significant additional clinical studies and regulatory submissions will be required to obtain regulatory approval from the FDA and other regulatory bodies before PMX-60056 could be commercially sold.

PMX-60056 represents an entirely new class of drug, which PolyMedix calls a heptagonist, and is said to be the only reversing agent for heparin and the low molecular weight heparins in clinical development.

Nicholas Landekic, CEO of PolyMedix, said: “The start of the clinical trial with PMX-60056 represents another major milestone for PolyMedix. This novel heptagonist compound is the first of its kind, and potentially represents a fundamental breakthrough both for cardiothoracic surgery and the treatment of bleeding problems with low molecular weight heparins.”

Grameen Health to Form Partnerships With Big Pharma

Grameen Health, an affiliate of Bangladesh-based Grameen Bank, has announced that it will establish independent partnerships with Pfizer, GE Healthcare, and Mayo Clinic to create sustainable models for healthcare delivery in the developing world.

According to Grameen Health, these multiple, independent collaborations will focus on social business models in which the businesses are self-supporting and any profits are re-invested into the system in order to reach more of the poor. This approach is cost-effective and maximizes the benefits that patients receive. The models will be transferable to other healthcare delivery systems.

The independent collaborations will initially explore and evaluate ways to improve the existing Grameen Health delivery and financing systems in Bangladesh, with the aim of creating models that can be adapted for the needs of the four billion people around the world whose annual income is less than $3,000.

Grameen Health and its partners hope to develop appropriate and sustainable models for healthcare delivery and rural primary care clinics, with the goal of replicating these models in other countries.

Pfizer is reportedly dedicating key employees to provide technical and advisory support to evaluate Grameen’s existing healthcare delivery systems in Bangladesh. GE Healthcare will test delivery of ultrasound capability in rural clinics for early detection of abnormalities, and Mayo Clinic will work to improve the training, efficiency, and retention of staff at existing Grameen Health Kalyan clinics.

In 2009, the collaborations will initially focus on – Implementing primary health promotion and disease prevention programs, analyzing ways to expand and improve the current low-cost micro-health delivery and insurance programs at Grameen Health’s 38 existing Kalyan clinics, developing continuous training programs for nurses, technicians and physicians, reviewing operating efficiencies and scope of services (telemedicine, mobile health care) at Grameen Health’s Kalyan clinics.

Omar Ishrak, president and CEO, clinical systems, GE Healthcare, said: “With the ubiquitous usage of ultrasound, GE believes it’s provided a crucial tool in the early care of expectant mothers. We intend to work with Grameen Health to further understand and expand ultrasound usage in rural areas. Through this pilot program we plan to train providers in the usage of ultrasound, evaluate the product, the training and the workflow that would be needed to enable the full deployment of this technology.”

Muhammad Yunus, founder of Grameen Bank, said: “As we address the challenges of global health access, we are pleased to partner with these and other organizations that share our belief that solutions to improving access to medicines and healthcare can be socially responsible and sustainable, yet commercially viable.”

Popular Musician LaMotte Making Winthrop Stop

By Mary Jo Balasco

Appalachian folk musician David LaMotte will perform at 8 tonight at Dinkins Underground, Winthrop University. Cost is $7 or $5 with Winthrop I.D. This could be the popular performer’s last area show before he retires. For details, visit www.winthrop.edu/ studentaffairs/dsu or www.davidlamotte.com.

Bible teacher Alan Vincent speaking Sunday

Alan Vincent, an international Bible teacher, will speak at 10 a.m. and 6:30 p.m. Sunday at Antioch International Church at the NarroWay Theatre and Conference Center, 3346 U.S. 21, Carowinds Blvd., Fort Mill. For details, contact Pastor Matt Woodhouse at (803) 493-0955 or visit www.LifeAtAntioch.org.

Pottery festival, films among museum offerings

Culture and Heritage Museums will have the following events this weekend:

* The Piedmont Pottery Festival will be from 10 a.m. to 4 p.m Saturday at Historic Brattonsville, 1444 Brattonsville Road, McConnells. The event includes demonstrations, items for sale and discussions by potters. Admission is $10 adults; $8 seniors; $5 youth ages 4 to 17; free for ages 3 and younger; members receive at $2 discount. For details, call 684-2327 or visit www.chmuseums.org.

* A viewing of portions of historical films “The Southerner” and “The Southern Negro” will be at 1 p.m. Saturday at the McCelvey Center, 212 E. Jefferson St., York. These four 30-minute segments were filmed in York in 1958. A brief discussion and question session will follow the screening. The event is free. For reservations or details, call 684-3948, Ext. 27.

Andrew Jackson park hopping with music

The Carolina Legends Festival will be from 6 to 9 p.m Friday and 10 a.m. to 9 p.m. Saturday at Andrew Jackson State Park. Tickets are $5 Friday; $15 Saturday; or $18 for both days. The event includes food, art, live music and kids activities provided by the City of Lancaster Fire Department. For details, call Christina at the Lancaster County Council of the Arts, (803) 285-7451, Ext. 27.

Great Falls celebrating heritage, town

The Great Falls Heritage Celebration will be from 7 to 10 p.m. Friday and 10 a.m. to 4 p.m. Saturday at the War Memorial building, 401 Dearborn St., Great Falls.

Friday events will be a celebration of art and include music, theater, arts exhibits, book signings, food and silent auction. The auction benefits the Great Falls Home Town Association. Saturday events include a barbecue sale, indoor and outdoor art exhibits, performances, children’s activities and more. Admission is free. For details, call Glinda Coleman at (803) 482-2370 or e-mail her at [email protected] or Cherry Doster at (803) 287-7853 or e- mail her at [email protected].

‘Plaza Suite’ playing two weekends in Fort Mill

The Fort Mill Community Playhouse dinner theater production of the Neil Simon’s classic “Plaza Suite” will be today through Saturday and Oct. 3 and 4 at the theater, 615 Banks St. Doors open at 6:30 p.m. with a cash bar, dinner is at 7 p.m. and the show starts at 8 p.m. Reservations are required a week in advance. Cost is $25 members and $35 non-members. For reservations, call 548-8102 or e-mail [email protected] or visit www.fortmillplayhouse.org.

Horse show Saturday at Close Greenway

The 12th annual Anne Springs Close Greenway horse show will begin at 9:30 a.m. Saturday at the greenway. Class registration is $8 per horse per class. Admission is free, but donations are accepted. Proceeds will benefit the Greenway’s new way-finding initiative. For details, call the greenway at 548-7252.

Mr., Miss Amicae will be named Sunday

The annual Mr. and Miss Amicae Pageant will be at 4 p.m. Sunday at Hermon Presbyterian Church, 107 Heckle Blvd., Rock Hill. Proceeds benefit annual scholarship and local charities.

Disc golf clinic Oct. 11 for ages 6 to 12

A youth disc golf clinic for ages 6 to 12 will be from 9 a.m. to noon Oct. 11 at Fewell Park, 1204 Alexander Road, Rock Hill. The Rock Hill Parks, Recreation and Tourism and Innova Disc Golf are sponsoring the event. For details, call Ansley at 329-5646 or visit www.rockhillrocks.com.

AARP schedules driver safety classes

AARP driver’s safety program for ages 50 and older will be from 9 a.m. to 1 p.m. Oct. 7 and 8 at Park Point Village, 3025 Chesbrough Blvd., Rock Hill. Cost is $10. For details or to register, call Sandra Hinson at 327-4723 or Gene R. Esarove at 547-4553.

Exercise, art at Baxter YMCA

The Fort Mill branch YMCA, 857 Promenade Walk Baxter Village, will have the following events:

* Exercise for Breast Cancer Awareness, 8 to 10 a.m. Oct. 4. Beauty products will be sold and all proceeds will be donated to breast cancer research. To register or for details, call 548-8020.

* Adult Acrylic Art Classes for beginner and intermediate level with Jack Bolin, 6 to 8 p.m., Wednesdays beginning Oct. 8 through 29. For details, call Karen at 548-8020, Ext. 259.

* Adult Watercolors Art Classes with Sandy Brindle, 1 to 3 p.m. Wednesdays beginning Oct. 8 through 29. For details, call 548- 8020, Ext. 259.

* Gymnastics for ages 2 to 5, 12:15 to 1:15 p.m. and 2:30 to 3:30 p.m. Thursdays; ages 6 to 12, 6:30 p.m. Thursdays. For details, call 548-8020 or e-mail [email protected].

* Registration for Biddy basketball, ages 5 to 6, members Oct. 6 through Nov. 17; non-members Oct. 13 through Dec. 3. Practice will be on Wednesdays beginning Dec. 3. For details call 548-8020 or e- mail [email protected].

* Registration for Basketball League for ages 7 through 15, members Oct. 6 through Nov. 17 and non-members Oct. 13 through Nov. 17. For details, call 548-8020 or e-mail [email protected].

Groups plan fundraisers over next weeks

The following will have fundraisers:

* The Rock Hill Ecumenical Chorale, directed by D. Jeffery Sligh, is hosting the third annual Taste-N-Tell Extravaganza “Get Spoon- Fed” from 6 to 8:30 p.m. Saturday at Mt. Prospect Baptist Church, on the corner of West Black and Allen Streets. The event benefits the annual Christmas Concert to be held Dec. 21 at Oakland Baptist Church. The Christmas concert is sponsored by the choirs of Mt. Prospect Baptist and St. Mary’s Catholic Churches. For details or advance Christmas concert tickets, call Dorothy Hunter 909-9050, Johnnie McCoy 329-0521, Wendi Carter (704) 996-4420 or Sarah Chisolm at St. Mary’s Catholic Church.

* The York County Mommies, a non-profit organization, is seeking participants for a yard sale Oct. 25. For details, call Brandi at (803) 448-0950 or e-mail her at [email protected].

* The third annual Northwestern High School Invitational Volleyball Tournament will begin at 8 a.m. Saturday at Northwestern High School, Rock Hill. All profits from the tournament will benefit the school’s volleyball program. The event is open to the public. Admission is $5 adults; $3 seniors and children age 10 and younger; free for children kindergarten age and younger. For details, call Coach Cesar Robles (803) 984-2506.

* The Animal Adoption League will have a pet adoption day from noon to 3 p.m Saturday at Animal Supply House, 1025 N. Anderson Road, Rock Hill. Hot dogs will be sold to benefit the adoption league. Volunteers are needed for this event. For details, call the store at 366-2959.

* The United Way of York County will kick off its annual fundraising campaign with its United Men of York County Showcase event beginning at 6 p.m. Thursday at the Palmetto Room, downtown Rock Hill. From 6 to 8 p.m. attendees can vote for 29 men competing for one of 12 spots in the 2009 United Men of York County calendar. For details, call 324-2735 or visit www.unitedwayofyc.org.

Community theater needs ‘Little Red’ star

Carolina Community Theatre is seeking one experienced actress for its upcoming children’s musical production, “The Adventures of Little Red.” The actress should be able to sing, play a younger character and be available for daytime shows/ rehearsals. To schedule an audition, call Chip Brazil at (803) 524-7200.

Grant-writing offered for non-profits

A grant-writing workshop for non-profit organizations will be from 9 a.m. to 2 p.m. Saturday at Holiday Inn Express Hotel, 805 West Arrowood Road, Charlotte. Cost $95 per person or $160 per couple. For details, call Susan Woods at (704) 968-2769 or visit www.susanseminars.org.

Youth-led projects can earn Rock Hill grants

The Rock Hill Youth Council grant program is awarding grants of up to $500 to youth-led projects. A grant workshop will be 10 to 11:30 a.m. Oct. 18 in room 373 at the City of Rock Hill, 155 Johnson St., Rock Hill. Application deadline is Nov. 7. Applications are available online at www.rockhillrocks.com. For details, call Patti Panetti, youth program director at 329-5625.

VFW hosting banquet for past commander

The Veterans of Foreign Wars Post No. 2889 will have a banquet and presentation for Johnnie Robinson, past commander, at 8 p.m. Saturday at the facility, 732 W. Main St., Rock Hill. The free event is for members only.

4-Hers, writers among those meeting

These groups/clubs will meet:

* The Teen 4-H Supper Club for grades 7 and higher will meet from 4:30 to 6:30 p.m. on select Fridays at the York County Extension Office, York. Dates are Nov. 21, January 9, February 6, March 6 and April 3. Members will learn about food preparation and will have supper together. Cost is $20. To enroll, call the extension office at 684-9919, Ext. 113.

* The 4-H Drama Club for ages 9 to 19 will meet from 10 a.m. to noon Saturday at the Market Building, 116 Columbia St., Chester. For details, call (803) 385-6181, Ext. 0.

* The Rock Hill Council of Neighborhoods will meet at 6:30 p.m. today at the Housing and Neighborhood Services office, 150 Johnson St., Rock Hill. Speakers will be from Rock Hill Clean and Green.

* A new fiction writer’s group will meet at 4:30 p.m. today in room 113 in the Anne Springs Close Library at York Technical College. Participants are encouraged to bring their work. The group will meet monthly. For details, call Martha Macdonald at 981-7341 or e-mail her at [email protected].

* The York County board of Rural Fire Control will meet at 6:30 p.m. today at the Fire Training Center. A meal will be provided at 6:30 p.m., a demonstration of gas monitors will be at 7 p.m. and a meeting will follow.

Divorce workshop planned Oct. 6

South Carolina Legal Services will have a Pro Se Divorce Clinic at 2 p.m. Oct. 6 at the York County Library, 138 E. Black St., Rock Hill. The instructional clinic, conducted by attorneys, is for those seeking a divorce that meet specific criteria. For details, or to register, call South Carolina Legal Services at 327-9001 or 1-800- 922-3853 and press 0.

Brush up on boat safety at weekend class

A boating safety class will be from 9 a.m. to 5 p.m. Saturday and Oct. 25 at the Lake Wylie Public Library, 185 Blucher Circle, Rock Hill. The class will be conducted by the U.S. Coast Guard Auxiliary Flotilla 17-05 Lake Wylie and is $40 per person. For details, call Brian Groves (803) 367-2519 or visit www.cgalakewylie.org.

Humane Society sets adoption drive

The Humane Society of Lancaster will have an adoption drive from 5 to 7 p.m. Friday at the office, 126 S. Main St., Lancaster. In honor of October being National Awareness month the humane society will offer low cost adoptions through Oct. 31. For details, call (803) 285-5683.

Hensley family will gather Saturday

The Hensley family reunion will be at 10 a.m. Saturday at the Hensley home, 1373 Hensley Road, Fort Mill.

Free programs available at Resource Center

The Rock Hill Family Resource Center, 217 Orange St., Rock Hill, offers the following events:

* Free medical clinic, 8:30 a.m. to 3:30 p.m. Friday, The clinic is for children birth through 18 who do not have medical insurance or Medicaid. For appointments, call (803) 322-6636 or for details, call 980-2079.

* Free parent and child together activities, 10 a.m. to 11:30 a.m. Friday. For details, call 981-1557.

[email protected]

Community news is published on Thursday and Sunday. Deadline for the Thursday column is 5 p.m. Monday. Deadline for the Sunday column is 5 p.m. Wednesday.

(c) 2008 Herald; Rock Hill, S.C.. Provided by ProQuest LLC. All rights Reserved.

Road2ACure Launches Road2ACure: The California Ride and Rally for Pancreatic Cancer Awareness As Official Kickoff Fundraiser

CAMARILLO, Calif., Sept. 25 /PRNewswire/ — On October 12, 2008 Road2ACure kicks off its first official fundraiser, Road2ACure: The California Ride and Rally at Grove Park in Camarillo, CA raising awareness for pancreatic cancer and revving up for its upcoming 50 state motorcycle and documentary tour commencing February 2009.

At the October 12th event Chris Calaprice, co-founder of Road2ACure and five-year pancreatic and melanoma cancer survivor will lead bikers in a stunning ride beginning with a parade through downtown Ventura drawing attention to pancreatic cancer and its urgent need for funding and research. The ride continues along the coastline and through Ventura County’s canyons and back to the starting point for a final rally with vendors, competitions, family friendly activities, raffle prizes, and many auction items. Riders and non-riders can chow down on a BBQ lunch, and party to the sounds of the Flailington’s, the Voodoo Dogs, and the Guinness world record holder for fastest harmonica player; Nicky Shane. Rider registration opens at 8:30am; ride begins at 10am; rally starts at 12pm. Online pre-registration is $25 per person, $30 day of, and children under 10 are free.

This initial kickoff ride underscores Road2ACure’s mission to raise national awareness for pancreatic cancer, creating hope for survivors, their families and volunteers with media attention to help raise funds and ultimately find a cure for this deadly disease. Beginning February 21-October 11, 2009, Chris embarks on a 50 state motorcycle tour with a live film crew documenting the ride. Along the way, Chris and his wife Jennifer, Road2ACure president, will organize rides and rallies throughout the country modeled after the October 12th ride. They will be visiting pancreatic cancer survivors, caregivers, volunteers, grassroots activists, policy makers, oncologists, medical centers and local and federal legislators to drive home the necessity for progress in early detection, treatment and finally a cure. Chris, who has been receiving chemotherapy since his cancer diagnosis in 2003, will continue his treatment while on the tour that spans over 20,000 miles.

Highlighting the ride’s significance, Chris explains, “We need to make some noise and shed the spotlight on this bogeyman cancer. We must speak for those busy in the fight for survival, for those who have lost the battle, and for the 37,000 plus other Americans who will be diagnosed with pancreatic cancer this year alone.” Chris concludes insisting, “I believe in the power of people to make change through action. It is time to act NOW.”

Pancreatic cancer is the 4th leading cause of cancer death in the United States, yet its funding accounts for less than 2% of the National Cancer Institute’s annual budget. Over 37,000 Americans will be diagnosed with pancreatic cancer this year alone; only 25% will survive more than a year. Only 5% will survive past 5 years. Because pancreatic cancer is one of the few cancers for which survival has not improved substantially over the past 25 years, there is the need to raise such awareness and funding NOW. Road2ACure was founded with the intention of bringing this urgency to the forefront of the public’s attention.

Jennifer and Chris Calaprice became involved in the fight against pancreatic cancer in October of 2003 when Chris was diagnosed with pancreatic cancer. Together with friends, family, and the Pancreatic Cancer Action Network, they launched their 1st motorcycle Ride for Hope and rally that raised $40,000. Its success spurred them to want to do more and have a more far reaching impact. Road2ACure, a 501(c)(3) non-profit organization (paperwork finalization in progress) was their answer to making their own fight have a global impact. Dedicated to raising awareness and funds for pancreatic cancer, Road2ACure is endorsed by the Pancreatic Cancer Action Network.

For more information on Road2ACure The California Ride and Rally, the 50 State Motorcycle Tour and Documentary or to receive information on donating, please visit us online at http://www.road2acure.org/.

    CONTACT:    Jennifer Calaprice, President    Road2ACure    (661) 702-9202 (805) 455-5235    [email protected]    http://www.road2acure.org/  

Road2ACure

CONTACT: Jennifer Calaprice, President of Road2ACure, +1-661-702-9202,+1-805-455-5235, [email protected]

Web site: http://www.road2acure.org/

Jan Answers Your Questions

By JAN DE VRIES

I have been diagnosed with chronic fatigue syndrome. Symptoms include extreme tiredness, heavy aching muscles, flu-like symptoms with swollen glands, migraines, burning swollen joints and numbness in legs and arms.

It is essential to build up a healthy immune system with rest, sleep and appropriate dietary management. In addition, herbal and vitamin supplements can help to support the body’s nervous and digestive system, as well as boost the immune system. It is difficult to advise on general diet as allergic reactions arising from a depressed immune system vary greatly from sufferer to sufferer.

However, certain foods should certainly be avoided and this would include fermented products, cheese, wine, mushrooms and chocolate. The diet should be as natural as possible and avoid foods containing artificial preservatives, colourings and flavourings.

Also exclude refined white flour and sugar. The remedies Daily Choice Antioxidant, Eleutherococcus, and Energy Factors, would be beneficial.

My daughter was recently involved in a car accident. Although she was not physically hurt, since the accident she is crying all the time and doesn’t want to leave the house. Can you advise me how best I can help her?

I am very sorry to hear of your daughter’s recent accident, and the effect it has had on her. I would recommend that she use a remedy called Zincum Valerianicum at a dose of 15 drops, twice a day in a little water. This remedy is a combination of Zinc and Valeriana. The maintenance of health of several body systems, such as nervous, immune and reproductive systems, are influenced by zinc, and Valeriana is as effective as many conventional tranquillisers, beneficial in alleviating symptoms associated with anxiety and nervous tension.

I am a female in my late 50s and I am having trouble with my legs and ankles, which are always swollen. I have to wear trousers all the time, and would love to be able to wear skirts again. Can you help me?

I feel that you would benefit from taking some Vitamin E at a dose of one 400iu capsule twice a day, which will help with the circulation, together with Time Release Calcium Pantothenate at a dose of one tablet twice daily.

As a result of pregnancy I have had high blood pressure and currently take 25mg atenolol. I am presently breastfeeding my 12- week-old baby but feel very panicky and scared. I don’t want to take anything that will affect my wellbeing or breastfeeding. Can you suggest a quick and safe remedy to take?

I am sorry that you are feeling a bit panicky and scared. However these emotions are perfectly natural and I am sure that now you have had your baby, your blood pressure will begin to return to normal. As you are breastfeeding, I would not like to recommend any treatment for you.

Originally published by JAN DE VRIES HEALTH MATTERS [email protected].

(c) 2008 Belfast Telegraph. Provided by ProQuest LLC. All rights Reserved.

Hype Over New Cancer Drug May Give False Hope to Women

By Martin Eatock

A new drug called Lapatinib was recently hailed a “big step forward” for women suffering from advanced breast cancer. Consultant medical oncologist at the Belfast City Hospital, Dr Martin Eatock, argues that its true impact could be limited

Lapatinib, used in combination with the chemotherapy drug capecitabine, was recently licensed for the treatment of Her-2 positive advanced breast cancer, an aggressive form of the disease which affects around a quarter of those women diagnosed. It has been licensed for the treatment of women whose disease has progressed despite previous treatment with other chemotherapy drugs, including Herceptin.

The trial, on which this licensing decision was made, demonstrated that the combination of lapatinib and capecitabine resulted in a response rate of 24% among those taking part in the trial, compared to 14% for capecitabine alone, and an average improvement of eight weeks.

This has not yet resulted in a survival advantage. I would therefore question whether this is truly a “big step” forward. In fact, in a disease, which now has a survival often measured in years, this can at best be described as a modest benefit. I do not, however, write to belittle the potential that this drug has, the results of further clinical trials in patients who have travelled a shorter distance in their cancer journey are currently awaited.

The use of this drug in the NHS has to be considered in relation to other new drugs. Following the introduction of Herceptin for the treatment of early Her-2 positive breast cancer, a system to advise the Regional Medical Services Group (a local commissioning group for specialised healthcare) on the prioritisation of drugs for funding within the NHS here was put in place under the auspices of the Northern Ireland Cancer Network (NiCan).

In the last three years, 15 business cases for new drugs in the treatment of cancer have been considered and 11 of these funded, representing an uplift in the budget for cancer drugs in Northern Ireland from Pounds 12m to Pounds 18m. No business case has yet been received by NiCan for the use of lapatinib in advanced breast cancer.

Despite the success of this programme, the needs of cancer patients have to be considered in relation to the the wider needs of other patients in the NHS. The only way cancer drugs may be compared with drugs for the treatment of heart disease or psychiatric illness is to compare their cost effectiveness.

The National Institute for Clinical and Health Excellence (Nice) has sought to do this over the last nine years in England and Wales. Northern Ireland has been subject to Nice guidance since July 2006. Cost effectiveness of a new agent is assessed by looking at the cost per ‘quality-adjusted life-year’ gained, a system which gives each treatment a score for the benefit it gives in quality and length of life.

The cost per quality-adjusted life-year gained for lapatinib is estimated to be around Pounds 80,000 and it is therefore unlikely that this will be deemed to be cost effective by Nice, particularly as other new drugs for cancer treatment such as bevacizumab for colorectal cancer with a similar cost effectiveness ratio have not been approved.

Media coverage of the potential benefits of lapatinib is likely to lead to distress for a number of women with breast cancer who will now feel that they are being denied a very effective treatment. Examination of the facts, however, highlight the limited benefit of this drug and would lead to a better informed discussion of the issues around funding of new drugs.

As a cancer physician, I want the best care for all patients with cancer, however this is not necessarily represented by having access to every new drug immediately it is licensed.

Instead, best care reflects the need for the adequate resourcing of cancer services throughout the province to allow equitable access to high quality care, including adequate access to clinical trials examining the true impact of new agents for cancer treatment.

(c) 2008 Belfast Telegraph. Provided by ProQuest LLC. All rights Reserved.

J.D. Power and Associates Reports: Flat-Rate Pricing for Generic Prescriptions May Lead to Higher Satisfaction Among Pharmacy Customers

WESTLAKE VILLAGE, Calif., Sept. 25 /PRNewswire/ — Pharmacy customers who participate in flat-rate generic prescription pricing programs have considerably higher levels of satisfaction, compared with customers who don’t participate in these programs, according to the J.D. Power and Associates 2008 National Pharmacy Study(SM) released today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-a)

The study, now in its second year, measures customer satisfaction with pharmacies in two segments: brick-and-mortar and mail order. Covering retail chain stores, supermarkets and mass merchandisers, the study examines seven key factors that contribute to customer satisfaction for brick-and-mortar pharmacies: non-pharmacist staff; store convenience; medication availability and information; layout and design; cost competitiveness; remote ordering convenience; and pharmacist. Five factors are measured for the mail order segment: ordering convenience; delivery convenience; medication availability and information; cost competitiveness; and customer service representative.

Satisfaction among brick-and-mortar pharmacy customers who participate in flat-rate prescription pricing programs averages 826 on a 1,000-point scale, compared with 817 among customers who don’t participate in these programs. Nearly one-fourth of pharmacy customers participate in a “$4 generic” or similar flat-rate prescription pricing program, with the greatest participation rate among customers 44 years and older.

“Flat-rate generic prescription pricing programs are becoming increasingly popular among pharmacies,” said Jim Dougherty, executive director of the healthcare practice at J.D. Power and Associates. “While low price alone is not a guarantee of satisfaction, customers find these programs especially appealing because of the low prices, and pharmacies may be able to attract new and repeat customers with the simplicity of the programs.”

   Study results by segment are:    Chain Pharmacies   Medicine Shoppe ranks highest with an index score of 873.    Mass Merchandiser Pharmacies   Target ranks highest with an index score of 847.    Supermarket Pharmacies-West   Ralphs ranks highest with an index score of 854.    Supermarket Pharmacies-Midwest   Hy-Vee ranks highest with an index score of 842.    Supermarket Pharmacies-Northeast   Wegmans ranks highest with an index score of 850.    Supermarket Pharmacies-South   Publix ranks highest with an index score of 879.    Mail Order Pharmacies   Prescription Solutions ranks highest with an index score of 864.   

The study finds that customers 65 years and older account for 26 percent of mail order prescriptions, compared with 18 percent of prescriptions filled at brick-and-mortar pharmacies. Among customers in this age group who use mail order pharmacies, satisfaction averages 861, compared with 835 among customers 55 to 64 years old and 799 among customers 18 to 54 years old.

“Health insurance and Medicare Part D have driven more seniors to utilize mail order pharmacies to obtain medications for managing chronic conditions, and these mail order pharmacies can improve customer experiences by making the ordering process quick and easy,” said Dougherty. “The mail order industry already has a large share of older customers, and that share should continue to grow as the baby boomer generation ages. As this industry changes and expands, companies will need to respond appropriately to ensure customers remain satisfied.”

The 2008 National Pharmacy Study is based on responses from 15,163 consumers who filled a new prescription or refilled a prescription during the three months prior to the survey period. The Web-based study was fielded June through August 2008.

   Customer Satisfaction Index Ranking   Chain Segment   (Based on a 1,000-point scale)    Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                          For Consumers   Medicine Shoppe        873              5    Health Mart            840              4    CVS/Pharmacy           815              3   Chain Segment Average  805              3   Walgreens              799              3   Rite Aid               789              3   Longs Drugs            775              3    Duane Reade            691              2   

Included in the study but not ranked due to small sample size are: Aurora Pharmacy, Discount Drug Mart, Fred’s, Kerr Drug, Kinney Drugs, Medicap Pharmacy, Sav-More, Snyders Drug, Thrifty White and USA Drug.

   Mass Merchandiser Segment   (Based on a 1,000-point scale)    Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                          For Consumers    Target                 847              5   Kmart                  842              5   ShopKo                 837              4   Meijer                 833              4   Sam's Club             831              4   Costco                 813              4    Mass Merchandiser   Segment Average        802              3    Wal-Mart               779              2    Included in the study but not ranked due to small sample size is Pamida.      Supermarket Segment - West   (Based on a 1,000-point scale)    Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                          For Consumers   Ralphs                 854              5    Fry's                  827              4    West Segment Average   815              3   Vons                   810              3   Albertsons             807              3    Safeway                803              2   

Included in the study but not ranked due to small sample size are Bashas’ and QFC.

   Supermarket Segment - Midwest   (Based on a 1,000-point scale)    Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                          For Consumers   Hy-Vee                 842              5    Kroger                 827              3   Midwest Segment    Average               822              3   Jewel-Osco             814              3    Giant Eagle            806              2   Cub Foods              790              2   

Included in the study but not ranked due to small sample size is Dominick’s.

   Supermarket Segment - Northeast   (Based on a 1,000-point scale)    Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                          For Consumers   Wegmans                850              5    ShopRite               841              4    Stop & Shop            822              3   Northeast Segment    Average               817              3   Hannaford              804              3    Giant Eagle            777              2   

Included in the study but not ranked due to small sample size are A&P and Acme.

   Supermarket Segment - South   (Based on a 1,000-point scale)     Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                               For Consumers   Publix                 879              5    Kroger                 846              3   Winn-Dixie             844              3   South Segment Average  842              3   H-E-B                  832              3    Safeway                805              2   Giant                  773              2      Mail Order Segment   (Based on a 1,000-point scale)    Pharmacy               Index Score     J.D. Power.com Power Circle Ratings                                          For Consumers   Prescription    Solutions             864              5    Express Scripts        845              4    Medco                  833              3   Caremark/CVS           828              3   Mail Order Segment    Average               824              3   WellPoint/nextRx       820              3   Wal-Mart Pharmacy/    Mail Service          804              3   Walgreens Health    Initiatives Inc.      804              3    CIGNA Pharmacy    Management            803              2   Rite-Aid Health    Solutions             763              2   

Included in the study but not ranked due to small sample size are Aetna Rx Home Delivery and Drugstore.com.

About J.D. Power and Associates

Headquartered in Westlake Village, Calif., J.D. Power and Associates is a global marketing information services company operating in key business sectors including market research, forecasting, performance improvement, training and customer satisfaction. The company’s quality and satisfaction measurements are based on responses from millions of consumers annually. For more information on car reviews and ratings, car insurance, health insurance, cell phone ratings, and more, please visit JDPower.com. J.D. Power and Associates is a business unit of The McGraw-Hill Companies.

About The McGraw-Hill Companies

Founded in 1888, The McGraw-Hill Companies is a leading global information services provider meeting worldwide needs in the financial services, education and business information markets through leading brands such as Standard & Poor’s, McGraw-Hill Education, BusinessWeek and J.D. Power and Associates. The Corporation has more than 280 offices in 40 countries. Sales in 2007 were $6.8 billion. Additional information is available at http://www.mcgraw-hill.com/.

    Media Relations Contacts:    Scott Merritt                     John Tews    Brandware Public Relations        J.D. Power and Associates    Atlanta, Ga.                      Troy, Mich.    (770) 649-0880 ext. 302           (248) 312-4119    [email protected]       [email protected]   

No advertising or other promotional use can be made of the information in this release without the express prior written consent of J.D. Power and Associates. http://www.jdpower.com/corporate

Photo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-aAP Archive: http://photoarchive.ap.org/PRN Photo Desk, [email protected]

J.D. Power and Associates

CONTACT: Scott Merritt of Brandware Public Relations, +1-770-649-0880,ext. 302, [email protected], for J.D. Power and Associates; or JohnTews of J.D. Power and Associates, +1-248-312-4119, [email protected]

Web site: http://www.jdpower.com/http://www.mcgraw-hill.com/

Temple Israel Will Broadcast Rosh Hashanah and Yom Kippur Services on the Radio and the Internet

Temple Israel of Greater Miami is a Reform Congregation that has historically been known as a hub for liberal social action. Temple Israel will be broadcasting live, through the radio and the internet, Rosh Hashanah and Yom Kippur Services to benefit Jewish people around the world, who are homebound for any reason. Simply go to www.templeisrael.net and click on Services (left column) The schedule for both radio and internet is the same, Eastern Time:

 Erev Rosh Hashanah, Monday, September 29 7:30 PM - 9:00 PM (1360 AM) Rosh Hashanah, Tuesday, September 30 10:00 AM - 1:00 PM (1360 AM) Erev Yom Kippur (Kol Nidre), Wednesday, October 8 7:30 PM - 9:00 PM (880 AM) Yom Kippur, Thursday, October 9 10:00 AM - 1:00 PM 3:00 PM - 6:00 PM (880 AM) 

The Friday night Shabbat Services are also broadcast live through the radio at 880 AM and through the internet (www.templeisrael.net) at 7:30 PM Eastern Time.

About Temple Israel

Temple Israel, founded in 1922, is celebrating 85 years as the oldest Reform Congregation in South Florida. Always a downtown temple, we continue to maintain our beautiful campus on NE 19th Street just 2 blocks west of Biscayne Boulevard.

Temple Israel is an inclusive congregation where all members and visitors can feel at home whether attending an inspirational Friday night Shabbat Service, or sharing bagels and ideas at the Saturday morning study group, or attending any one of the many programs to be found at the Temple throughout the year. Temple Israel values the diverse ways in which members can express their Jewish identities and are dedicated to creating and maintaining a sense of community, standing at the forefront of social change, supporting the struggle for civil and human rights for all, regardless of creed, color, sexual orientation, or national origin.

Concert Pharmaceuticals Initiates CTP-347 Phase I Clinical Trial

Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers. Concert intends to evaluate CTP-347 as a non-hormonal treatment for vasomotor symptoms (VMS or hot flashes) in patients with increased risk of adverse effects due to, or contraindicated to using, hormone therapy, as well as in the larger menopausal population. Results of this Phase I study are expected to be available in the first half of 2009.

“We are pleased to have advanced our first compound from concept to clinical testing in less than two years. We believe our deuterium chemistry platform holds great promise in creating novel compounds with superior safety and efficacy as compared to existing therapies. We look forward to advancing and introducing a number of first-in-class agents for unmet medical needs, of which CTP-347 is our first to enter the clinic,” said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals.

CTP-347 is Concert’s first compound to advance into clinical trials. CTP-347 is a new chemical entity developed from Concert’s deuterium chemistry platform by replacing key hydrogen atoms of paroxetine with deuterium. Paroxetine has been shown to be an effective treatment for VMS. However, it is a potent and irreversible inactivator of CYP2D6 (cytochrome P450 2D6), a key liver enzyme responsible for the metabolism of many commonly-prescribed drugs. In preclinical testing, CTP-347 demonstrated improved metabolic properties, significantly reducing CYP2D6 inhibition while preserving paroxetine’s pharmacological activity. Based on these results, Concert believes CTP-347 may avoid adverse interactions with many drugs, including tamoxifen and certain antiarrhythmics, beta-blockers, analgesics, and antipsychotics. The Company expects to investigate CTP-347’s drug-drug interaction profile as part of the Phase I study.

Currently, there is no FDA-approved non-hormonal treatment for VMS, a serious and sometimes long-term condition associated with a range of undesirable effects including depression, insomnia and lost productivity. Hormone replacement therapy can effectively treat VMS. However, patients who currently or previously have been treated for cancers of the breast or ovary, or who have a familial history of these cancers, are often advised to avoid hormonal treatment. A non-hormonal therapy may also be preferred by women who experience VMS following menopause in whom hormone therapy is contraindicated or who have concerns about long-term health risks posed by hormone replacement therapy.

About Deuterium

Concert Pharmaceuticals has created a broad pipeline by replacing specific hydrogen atoms in existing, clinically-validated drugs with deuterium atoms, resulting in highly differentiated new chemical entities with potential as best-in-class and first-in-class therapeutic agents. Deuterium is a safe, non-radioactive relative of hydrogen that can be isolated from sea water and has been used extensively in human metabolic and clinical studies. Since deuterium resembles hydrogen, deuterium-modified compounds are expected to fully preserve the pharmacological activity of their hydrogen analogs. An important difference is that deuterium has greater mass than hydrogen and therefore forms stronger chemical bonds. The stronger chemical bond obtained by selective deuterium modification may improve the drug’s metabolic properties, resulting in better safety, tolerability, and efficacy.

About Concert

Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative platform to create highly differentiated compounds starting from validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create drug candidates with potential for best-in-class efficacy and safety, while reducing R&D risk, time, and expense. The Company has over 100 patent applications for new drug candidates addressing a broad range of therapeutic areas, including vasomotor symptoms, HIV/AIDS and fibrotic diseases, among others. Since its inception in 2006, Concert has raised more than $96 million and has been financed by leading venture capitalists and institutional investors. A complete listing of Concert’s shareholders and additional corporate information is available online at http://www.concertpharma.com. CoNCERT and CoNCERT Pharmaceuticals are trademarks of Concert Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals Presents Positive Updated Data From Phase I/II Clinical Trial With TRIOLEX(TM) in Obese Insulin Resistant Subjects

Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today presented additional positive interim data from its on-going Phase I/II clinical trial with its investigational oral drug candidate TRIOLEX(TM) (HE3286) in obese insulin resistant subjects at the 6th World Congress on Insulin Resistance Syndrome, being held September 25th – 27th in Los Angeles, California. Dr. Jaime Flores-Riveros, Vice President, Endocrinology and Metabolism at Hollis-Eden Pharmaceuticals, presented the data.

The additional data extend findings previously reported in a corporate symposium held in conjunction with the 68th Scientific Sessions of the American Diabetes Association demonstrating that TRIOLEX is safe and well tolerated to date, and that it significantly improved insulin sensitivity and lowered fasting blood glucose and insulin levels in obese insulin resistant subjects treated orally with 5 or 10 milligrams of the compound administered twice daily for 28 days, as compared to placebo-treated subjects.

Dr. Flores-Riveros presented additional data showing that insulin resistant subjects (as defined by a physiological index of glucose disposal or M-value less than 5), displayed a significantly exacerbated inflammatory response characterized by higher levels of the pro-inflammatory cytokines MCP-1, TNF-alpha, IL-6 and IL-1beta produced in LPS stimulated peripheral blood mononuclear cells (PBMC) from these patients. In contrast to more insulin sensitive subjects (M greater than 5), treatment of these insulin resistant subjects (M less than 5) with TRIOLEX was associated with a positive trend towards lowering these inflammatory cytokines, which in turn was accompanied by signs of glucose lowering in the same subjects.

Dr. Flores-Riveros also presented new data showing that retinol-binding protein 4 (RBP4), a protein secreted by fat cells that is associated with insulin resistance, was markedly decreased in the insulin resistant subjects (M less than 5) treated with TRIOLEX compared to placebo-treated subjects. In addition, C-reactive protein (CRP) was significantly decreased in the insulin resistant subjects (M less than 5) compared to placebo-treated subjects (p = 0.018). CRP is a well-known serum marker of inflammation, which has been linked to cardiovascular risk.

“The findings to date from this on-going clinical trial suggesting that initial serum CRP and levels of MCP-1, TNF-alpha, IL-6 and IL-1beta secreted by PBMC are elevated in insulin resistant subjects provide further rationale for the belief that insulin resistance is closely linked with inflammation,” stated William Cefalu, M.D., of Pennington Biomedical Research Center in Baton Rouge, Louisiana. “The trend observed to date in this on-going study that TRIOLEX appears to decrease these elevated inflammatory markers, as well as the previously reported interim data showing that TRIOLEX significantly improved insulin sensitivity in these subjects when compared to placebo-treated subjects, lend support for the continued clinical development of TRIOLEX. If successfully developed, TRIOLEX has the potential to be an anti-inflammatory pharmaceutical that may provide benefit in type 2 diabetes without the side effects associated with the current glitazone class of insulin sensitizing agents as well as potentially providing benefit for diabetes-associated cardiovascular events.”

TRIOLEX may represent a novel, first-in-class insulin sensitizer that Hollis-Eden believes acts by modulating inflammatory pathways. Leading academic researchers have linked inflammation and type 2 diabetes, reporting that chronic, subclinical inflammation can result in impaired insulin signaling by a variety of mechanisms. The involvement of inflammation through this pathway in causing insulin resistance and type 2 diabetes is well described in the scientific literature. In addition, activation of NF-kappaB due to inflammatory mediators or oxidative stress leads to a feed forward cycle of increased production of inflammatory cytokines such as MCP-1, TNF-alpha, IL-6 and IL-1beta.

The therapeutic approach inherent in Hollis-Eden’s drug candidate is to restore the biological activity of cellular signaling pathways disrupted by disease and aging. In the setting of type 2 diabetes, the Company believes that the mechanism of action for TRIOLEX may be the regulation of the NF-kappaB pathway and other proinflammatory pathways, particularly when these are stimulated through the TLR4 receptor. TLR4 is a receptor expressed on the cell surface of macrophages and other cells that is stimulated by certain pathogens such as bacteria and viruses or certain chemicals such as dietary fatty acids. Upon stimulation of the TLR4 receptor, a cascade of proinflammatory kinases that include IKK, JNK and p38 is activated, setting off a complex network of signaling pathways, which culminate with the activation of NF-kappaB and a number of genes involved in the inflammatory and cell stress response. Based on experiments conducted to date, TRIOLEX appears to act independently of the PPAR-gamma pathway and down regulates proinflammatory kinases JNK, IKK and p38, which have been associated with impairment of the insulin receptor substrate-1 protein (IRS-1) function, an important cellular mediator of insulin signaling, ultimately causing inappropriate insulin action. Since this mechanism for improving insulin sensitivity does not seem to occur primarily through the PPAR-gamma pathway, TRIOLEX may avoid the side effects associated with the current glitazone class of insulin sensitizing agents, such as Avandia(R) and Actos(R), which work through PPAR-gamma. Side effects reported to date with the glitazone class of drugs include weight gain, edema and increased cardiovascular events. To date, experiments in vitro have shown no evidence that TRIOLEX directly binds and/or transactivates the PPAR-gamma receptor. Unlike the glitazones, TRIOLEX does not cause body weight gain when administered to mice or rats.

Added Richard Hollis, Chairman and CEO of Hollis-Eden Pharmaceuticals, “Data presented today by Dr. Flores-Riveros at this World Congress on Insulin Resistance Syndrome is relevant to our goal of developing a novel, first-in-class insulin sensitizer addressing the role of inflammation in driving insulin resistance. We believe this data is exciting because it may reflect the inherent ability of TRIOLEX to down regulate specific inflammatory signaling pathways that are thought to impair insulin signaling when chronically stimulated. We are also examining several other parameters known to be dysregulated as part of the metabolic syndrome, which includes both triglycerides and cholesterol. If TRIOLEX is successfully developed, we believe that the ability to regulate both glucose homeostasis and inflammation may result in a better and safer insulin sensitizer and make a significant advancement in the treatment of type 2 diabetes as well as potentially be beneficial in mitigating the serious consequences associated with uncontrolled inflammation in cardiovascular disease. A new generation of novel steroid hormones that regulate inflammation without serious side-effects could have multiple medical uses and could offer medicine the ability to better manage immune-mediated diseases.”

Type 2 Diabetes Market

There are approximately 20 million Americans and over 160 million people worldwide with type 2 diabetes. As a result of an aging population and a rise in obesity rates, a common risk factor in this disease, the prevalence of type 2 diabetes is increasing rapidly. Included among the therapeutic approaches to type 2 diabetes are drugs designed to increase insulin production by the pancreas, drugs to reduce glucose production by the liver, and drugs to increase the body’s sensitivity to insulin, thereby improving glucose disposal by the blood stream. The global annual sales of oral anti-diabetic drugs exceed $11 billion annually. Of these insulin sensitizers, Avandia(R) and Actos(R) represent the largest class of oral anti-diabetic agents, currently garnering over $5 billion in worldwide sales annually. However, patient control of glucose levels remains a large unmet medical need as 64% of this patient population fails to achieve optimal glucose levels. Furthermore, now that it is increasingly understood that inflammation is at the root cause of insulin resistance, there is a need to address inflammation in type 2 diabetes.

About Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals, Inc. is a world leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals for human health. Through its Hormonal Signaling Technology Platform, Hollis-Eden is developing a new series of small molecule compounds that are metabolites or synthetic analogs of endogenous hormones derived by the adrenal glands from the body’s most abundant circulating adrenal steroid. These steroid hormones, designed to restore the biological activity of cellular signaling pathways disrupted by disease and aging, have been demonstrated in humans to possess several properties with potential therapeutic benefit — they regulate innate and adaptive immunity, reduce nonproductive inflammation and stimulate cell proliferation. The Company’s clinical drug development candidates include TRIOLEX (HE3286), a next-generation compound currently in clinical trials for the treatment of type 2 diabetes and ulcerative colitis and being prepared for clinical trials in rheumatoid arthritis, and APOPTONE(TM) (HE3235), a next-generation compound selected for clinical development for cancer. In addition to these clinical development candidates, Hollis-Eden has an active research program that is generating additional new clinical leads that are being further evaluated in preclinical models of a number of different diseases. For more information on Hollis-Eden, visit the Company’s website at www.holliseden.com.

This press release contains forward-looking statements within the meaning of the federal securities laws concerning, among other things, the potential and prospects of the Company’s drug discovery program and its drug candidates and the benefits to be derived therefrom including the potential advantages of TRIOLEX compared to other treatment approaches, how TRIOLEX is believed to work and its potential for use in the treatment of type 2 diabetes. The inclusion of forward-looking statements should not be regarded as a representation by the Company that any of its plans will be achieved. Any statement included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause the Company’s actual results to differ materially from historical results or those expressed or implied by such forward-looking statements. Such statements are subject to certain risks and uncertainties inherent in the Company’s business, including, but not limited to: the outcome of final analysis of data from the Company’s phase I/II clinical trial of TRIOLEX once it is completed may vary from the Company’s initial analysis and findings, and the FDA may not agree with the Company’s interpretation of such results; the ability to complete preclinical and clinical trials successfully and within specified timelines, if at all; the risks and uncertainties inherent in clinical trials, and drug development and commercialization, including the uncertainty of whether results in clinical testing of TRIOLEX to date will be predictive of results in later stages of development; the ability to obtain regulatory approval for TRIOLEX (HE3286), APOPTONE (HE3235) or any other investigational drug candidate; the Company’s future capital needs; the Company’s ability to obtain additional funding; the ability of the Company to obtain and protect its intellectual property rights and to not infringe the intellectual property rights of others; the development of competitive products by other companies, the market potential for type 2 diabetes, and the Company’s ability to compete; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are qualified in their entirety by this cautionary statement. Except as required by law, the Company undertakes no obligation to update or revise the information contained in this press release as a result of new information, future events or circumstances arising after the date of this press release. None of the Company’s drug candidates has been approved for sale, significant additional animal and human testing is required in order to seek marketing approval for any of its drug candidates, and the Company cannot assure you that marketing approval can be obtained for any of its drug candidates or that, even if such marketing approval were received, such drug candidates would ultimately achieve commercial success. Furthermore, as is typically the case at this stage of the regulatory review process, the FDA has not yet performed an in-depth review of the Company’s preclinical and clinical data, so its views remain subject to change.

Lady of America Fitness for Women Signs Multi-Unit Franchise Development Deal LOA to Further Expand Franchises for Women’s Fitness

Lady of America Franchise Corporation (LOAFC), franchisor of the LOA Fitness for Women and Lady of America fitness club brands, recently signed a development agreement with prominent existing Franchisee, John Gauthier. Gauthier, who currently owns and operates 10 Lady of America and LOA Fitness for Women locations. Gauthier will expand the new franchise locations throughout the Dallas area, Oklahoma and Massachusetts. This new agreement is the foundation for the fitness chain’s expansion of this all encompassing concept.

“These new development agreements demonstrate that we are well positioned for growth,” said Gerry Weber, president and CEO of Lady of America Franchise Corporation, the chain’s parent company. “In the last three years, we have launched a new prototype, brand strategy and concept. The LOA Fitness for Women of today is very different than its sister concept, Lady of America, and the franchise community is noticing.”

According to Weber, Lady of America Franchise Corporation was impressed with the financial performance of the current franchisee. “We have developed a concept that would allow us to maximize sales volume and return on investment,” he said. “The first fitness centers to be opened under the deal are expected to open in late 2008 with a total of 10 clubs to be opened.”

Lady of America (LOA) Fitness for Women Centers offer a complete workout experience to help members achieve their fitness goals. The women-focused centers were also first among the competition to provide Zumba classes to members, and strength and toning equipment designed specifically to fit women’s smaller frames. Lady of America Fitness for Women’s full-service clubs also feature Pilates, Yoga and aerobics classes alongside amenities such as sauna, tanning, childcare, massage, personal training and more. “These developments are an important strategic step in company growth, and we are especially pleased to be working with a Franchisee that has such a great track record.”

About Lady of America Franchise Corporation for Women’s Fitness

For over 20 years, Lady of America Franchise Corporation (LOAFC), franchisor of the Lady of America, Ladies Workout Express, Workout Express and Health Clubs of America fitness centers, has been an innovator in the constantly evolving business of women’s fitness. Lady of America Franchise Corporation was established in 1984 with the goal of providing a dynamic and supportive environment to hundreds of thousands of women working on their fitness and lifestyle goals in a safe and comfortable setting while enjoying the company and support of other women. Today LOAFC is one of the largest chains for women’s fitness centers with over 400 franchises in operation across 45 states and nine countries.

New Hope for Patients With Advanced Liver Disease

MINNEAPOLIS, Sept. 25 /PRNewswire/ — While there are many causes of advanced liver disease, fatty liver, or NASH (nonalcoholic steatohepatitis), has become the second leading cause of liver transplant in the United States. Obesity, along with elevated cholesterol and diabetes, has long been known to cause increased fat stores, which may be injurious to the liver.

Such was the case in Sonny B., a patient at Atlanta Health Institute. Sonny had a long history of obesity and had tried many weight loss programs over the years. During his youth, weight was simply a nuisance that didn’t prevent any activities. As time passed, Sonny developed diabetes, hypertension, elevated cholesterol and sleep apnea. He was noted to have elevated liver enzymes, and fatty liver, or NASH, was suspected.

Physicians often suspect this condition in patients with abnormal liver tests on their blood work or with an ultrasound of the liver showing increased fat. A confirmation of the diagnosis often requires a liver biopsy and a study of the liver tissue under the microscope. Unfortunately, NASH can induce inflammation and scarring in the liver, resulting in cirrhosis and organ failure.

Sonny’s diagnosis of cirrhosis and the development of some very dangerous complications came despite his best efforts to lose weight. He began having episodes of confusion (encephalopathy), life-threatening intestinal bleeding (esophageal varices), and abdominal and leg swelling (ascites/peripheral edema). Sonny’s liver appeared to be severely compromised, and a liver transplantation was recommended at a well-known university liver transplant center. To his dismay, Sonny did not qualify for transplant due to his excessive weight-502 pounds. He needed to lose 150 pounds before he could be considered-a near impossible feat considering his severe medical problems and deconditioning.

“The management of fatty liver and NASH has consisted of better diabetes and cholesterol control and weight reduction in the obese,” said Dr. William Lyday, GI/Liver subspecialist and co-founder of the Atlanta Health Institute. “Sadly, many patients with this condition are unable to lose sufficient weight and may be too unhealthy for liver transplant. Many patients with NASH succumb to their disease, developing end-stage liver disease, and for various reasons cannot qualify for liver transplant.”

In a desperate attempt to save Sonny’s life, his wife Marilyn encouraged him to enroll in a new weight management program in Atlanta. Dr. Lyday and Hitesh Chokshi, both GI/Liver subspecialists at the Atlanta Health Institute, were using the OPTIFAST(R) nutritional products in their weight management programs. Upon their direction, Sonny began an intensive program of calorie restriction, weekly meetings with a doctor and dietitian, and a weekly class with other OPTIFAST patients.

In the past, patients like Sonny B were often considered hopeless cases and too high risk to undergo weight loss therapies. However, the combination of GI/Liver specialists using OPTIFAST nutritional products resulted in almost immediate benefits. Within two weeks, Sonny was off all his diabetes medications, and over the following weeks he stopped all of his blood pressure medications. His swelling decreased, his mental function improved and his activity level skyrocketed. After losing close to 100 pounds in just two months, Sonny is a new man, with very few obvious symptoms to suggest liver disease. His liver function may very well continue to improve, making liver transplant unnecessary. Time will tell, but Sonny is happy with his newfound health that he didn’t believe was possible just two months ago.

Sonny will continue in the OPTIFAST weight management program at the Atlanta Health Institute as the doctors transition him back to eating regular foods. Upon reaching his weight loss goals, he will remain in Atlanta Health Institute’s lifelong maintenance program which also utilizes OPTIFAST products and prevents recurrence of obesity.

About Atlanta Health Institute, LLC

Atlanta Health Institute, LLC, is open to all patients desiring healthy, long-term, weight loss. They are especially capable of helping individuals with complex medical problems that need extra attention as they lose weight. Patient’s can register for classes via their website: http://www.wellnessatlanta.com/

About OPTIFAST

OPTIFAST was developed in 1974 to fill the growing need to treat obesity in a healthy, effective way. As diseases related to obesity became more prevalent, and more and more people began taking drastic measures to treat the problem, OPTIFAST was introduced as a sensible option for lifestyle transformation. The OPTIFAST experience is one of the most comprehensive weight loss options available. The program combines support and counseling, lifestyle education, and medical monitoring with meal replacements to help people lose weight and reduce weight-related health risks. A team of dedicated medical professionals provide support. The OPTIFAST Program is available in over 400 clinics nationwide. For more information, to see patient stories and to find a clinic, visit OPTIFAST.com.

OPTIFAST

CONTACT: Carie Wlos of Hiebing, +1-608-256-6357, ext. 109,[email protected], for OPTIFAST

Web site: http://www.optifast.com/

Dutch Doctors Uncover Medical Fraud in Bangladesh

Dutch doctors uncover medical fraud in Bangladesh

BRUSSELS, Sept. 23 (Xinhua) — Doctors from an Amsterdam hospital have sounded the alarm about a possible fraud related to medication for the potentially fatal infectious disease of leishmaniasis, Dutch paper De Telegraaf reported Tuesday.

Two doctors from Amsterdam’s Slotervaart Hospital said they had discovered the scam while working in Bangladesh. Hundreds of Bangladeshi patients suffering from leishmaniasis, or black fever, had supposedly been treated with miltefosine for months. But the doctors found out that the medication they were given contained no active ingredients.

The two doctors then warned the Bangladeshi government, which has since traced hundreds of people who received the inactive medicine and has given them proper medication.

J. Beijnen, one of the two doctors, said the fake medicine was probably provided by a local pharmaceutical company. He said the Bangladeshi government has launched an investigation.

Miltefosine, an oral medicine, is produced by German drugs firm Zentaris.

(c) 2008 Xinhua News Agency – CEIS. Provided by ProQuest LLC. All rights Reserved.

American Heart Association Announces Start! Fit-Friendly Companies

To: NATIONAL EDITORS

Contact: Katie Bell of the American Heart Association, +1-214- 706-1345, [email protected]

Survey of Employees Proves Worksite Wellness Programs Work

DALLAS, Sept. 25 /PRNewswire-USNewswire/ — More than 900businesses across the nation have been recognized by the American Heart Association’s Start! Fit-Friendly Companies Program for promoting physical activity and health in the work place — a 20 percent increase over last year.

Start! is the American Heart Association’s national initiative to get Americans walking. Most adult Americans spend a majority of their waking hours at work — many in sedentary careers — increasing their risk for medical problems such as obesity, high blood pressure and diabetes.

Start! Fit-Friendly Companies Program participants implement various options to encourage physical activity, nutrition and culture enhancements such as on-site walking routes, healthy food options in cafeterias and vending machines, annual employee health risk assessments and online tracking tools. Those participants who achieve Platinum recognition — the highest tier — take the program a step further by actually measuring the outcomes of their wellness efforts.

Wellness programs have increased in popularity in recent years because they are economical and efficient ways to help offset increasing employee healthcare costs, according to an American Heart Association survey.

The survey also showed that fewer than one in five employees evaluate their employer as encouraging participation in their company wellness program extremely or very well. However, employees in these highly encouraging environments are more likely to participate in and value these programs.

“Physical inactivity is an epidemic in our country — we just don’t get enough exercise,” said, Dr. Timothy Gardner, president of the American Heart Association and medical director of the Center for Heart and Vascular Health at the Christiana Care Health System in Delaware. “Physical activity is one of the best preventive health measures there is, and people who find ways to incorporate more walking into their lives gain health benefits. Our study revealed that employees are far more likely to engage in a workplace wellness program like Start! if company executives promote it, which is underscored by securing the Start! Fit-Friendly designation from the American Heart Association.”

The biggest obstacles preventing employees from getting enough physical activity are the time constraints and responsibilities of their jobs. The American Heart Association’s answer to this is Start!, which aims to develop a corporate culture of physical activity by motivating employees to walk during their workday. Start! targets both individuals and companies and focuses on walking because it has the lowest dropout rate of any form of physical activity. The Association provides free toolkits to companies who want to implement a worksite walking program.

“Employees participating in wellness programs experience fewer sick days, improved quality of life and higher job satisfaction,” said Dave Josserand, chairman of the American Heart Association and executive vice president and chief strategic officer of The Dalton Agency in Jacksonville, Fla. “Wellness programs will continue to play an important role in the health of Americans in years to come. The evidence that participating employees realize health benefits is key; research shows that businesses can save as much as $16 for every $1 they spend on health and wellness.”

The list of 2008 Start! Fit-Friendly Companies and more information about the study conducted by Harris Interactive are available at www.heart.org/start. The Oct. 27, 2008 issue of FORBESmagazine will include a special advertising section that features all 2008 Start! Fit- Friendly Companies.

Companies interested in applying for recognition in the Start! Fit-Friendly Companies Program should contact their nearest American Heart Association office or download an application from the Web site. Applications are due in Januaryfor review by a volunteer expert panel.

Start! is sponsored nationally by SUBWAY(R) restaurants, Healthy Choice(R) and AstraZeneca.

SOURCE American Heart Association

(c) 2008 U.S. Newswire. Provided by ProQuest LLC. All rights Reserved.

A Call to Compassion

By Lollar, Daniel E

Your chance to give back to those who need it the most. I complained I had no shoes, until I met a man who had no feet.

Last Friday was a really bad day. After a month of slow collections, Friday was full of problems: workers’ comp issues, professional relationship squabbles and noncompliant, complaining patients. Then I went home to take care of an 84-year-old Alzheimer’s mother that night. Could my day go much worse? Somehow, I managed to muddle through it.

Sunday came, and it was announced that one of our church members, Karen Asher, DO, and her husband, Tom Asher, DO, were home from setting up shop in a remote bush hospital in war-torn Sierra Leone, West Africa. They would be speaking at 6 p.m. that night. Well, the Pistons were playing the 76ers at 7 p.m., and did I really want to sit through another church service? Trying to be a good example for my kids (and knowing I would still be able to get home for the second half of the game), we went to church.

It started out typical enough – stories about missed planes, companions lost, yadda, yadda, yadda. Nothing a traveler through Chicago or Atlanta hasn’t experienced. When the story got to the customs experience, it began to change. Every bag going through customs was being systematically torn apart and gone through. Karen reported their bags were packed tighter than a Chinese puzzle box and she didn’t know how they would get them back together. However, news of their arrival had preceded them. When the customs agent saw them, he asked if they were the doctors coming to work in the bush hospital. When he heard the answer, he said, “Doctors, whatever you’re bringing with you is fine with us,” and waved them through.

When they arrived at the hospital, culture shock, death and disease greeted them. A baby died of malaria that night, the first baby they had lost under their care in 20 years. The hospital operates, for the most part, without electricity, because there are only funds to run the generator four hours a day, and it costs $100 in fuel for those four hours. Welcome to Africa.

The stories continued: a child whose face and foot were torn up by a monkey; a man with tetanus carried for eight to 10 hours in terrible pain and spasms. He got a shot of valium to relieve some of his pain and died peacefully, while his weeping widow thanked the Ashers for easing his pain during his last hours (not threatening to sue, as would be the case here in the U.S.).

In our country, there is a 7.5 maternal mortality rate per 100,000 births. In Sierra Leone, it’s 270 per 100,000. Prenatal care is nonexistent for the most part. The women of that region are short and have small pelvic openings, but have large babies. This leads to many problem deliveries. In the bush, when a pregnant woman in labor is finally determined to be in trouble, she is carried 12 hours to the nearest hospital. Naturally, many women die.

People then wonder if the hospital is killing babies and mothers deliberately, generating a grave distrust. To overcome this, the doctors devised a simple chart of height and belly circumference given to the local “midwife” (this is a generous title, since it’s usually local women who have no training). Using the chart, along with a bag of rice as payment, the midwife measures the women and sends in those who are either too small or too big. Those outside the normal range are at high risk. For example, those who are too small might have a small baby and those too big might be carrying twins.

The second night, a pregnant woman was sent in after an aid station measured her as too small and could not detect a fetal heartbeat. Also hearing no heartbeat, Karen opted to do an ultrasound with a new battery-operated unit and detected a faint but diminishing heat rate. An emergency C- section brought forth a limp baby, not breathing, whom they finally saved. The mother named him Lazarus, since he had come back from the dead. The next lady tested had twins that were facing each other, with one breech and its chin hooked under the other baby’s chin. Apparently, the ultrasound is a very useful device; Karen later said that with it, she saw her first worms in the liver.

Sierra Leone recently was torn apart by civil war. A rebel army ravaged the area, with many child soldiers as young as 11 or 12 brutally hacking people to death with machetes and raping, shooting and pillaging. Entire villages were wiped out. Through this horror, the hospital stayed open, treating all who came in, including the rebels. The scars remain.

The country is desperately poor. Famine is a real prospect. The people work all day just to buy enough rice for that day. Watching Karen break down and cry while viewing a picture of three small boys cleaning up her plate of leftovers she was too hot to eat brought tears to my eyes at the suffering of these little ones. Yet, somehow, there is true magic there. She said if you close your eyes and count to 10 while holding up a soccer ball, 50 children will appear from nowhere and begin playing.

You may ask, what has this got to do with me? What has this got to do with chiropractic? At the beginning of this article, I quoted a saying my Depression-era, WWII-generation father used to tell me when I would bemoan the severity of my sheltered, teenage life. It’s fine for us here, in our abundance, to contemplate whether to join a PPO or an HMO, the amount of Medicare reimbursement we are going to get and even the types of shoes we are going to wear, but Karen’s patients (some literally) have no feet to stand on. Sierra Leone is desperately in need of doctors of all types. Tropical diseases we have studied but have never seen are a daily fact of life there. Malaria, sleeping sickness, dengue fever, tetanus, malnutrition, parasites and any other disease you can think of, thrives there. AIDS is decimating the entire region.

They have a medical college to train the native people. They will start with a class of 80 but only graduate seven to 10. Why so low? Not for lack of will or intelligence, but lack of supplies. They might have one anatomy text for 40 students. If you have texts that have been unopened for years, these books literally can save lives. If you have an extra Gray’s Anatomy, Hoppenfeld’s, Guyton’s, Harrison’s, McMinn’s Colour Atlas of Human Anatomy, orthopedic texts, optometry books – all of them will help immensely. I plan on going through my old texts and donating them. As Dr. Asher told me, “Anatomy does not change.” For the cost of book-rate postage, your old text can make a world of difference half a world away. If you get them to me, the mission will get them to Africa. Before you send them, please e-mail me with the titles and I will let you know which ones would help the most and will give you further instructions. Wouldn’t it be nice if they had an entire reference library and textbooks supplied by their chiropractic colleagues?

Also, for those of you who would like to make a difference, I am sure Karen and Tom Asher could put you to work for a short-term mission. Can chiropractic make a difference in Africa? Of course! I am sure much suffering could be alleviated by our care. Your life will never be the same. Karen and Tom are finding out what it means to be a doctor. They are family-practice physicians who are now in the role of surgeon, OBGYN, orthopedist, internist and even dentist. They are good, sincere doctors who have left everything, giving up a comfortable life and practice, leaving family, friends and their own culture, trying desperately to make a difference. Can we as a profession help out another colleague?

Knowledge is power; ignorance is death, disease, famine and suffering. So much we take for granted is unknown to these people. What could be done teaching simple hygiene? How many of us came from farming and construction backgrounds? The knowledge you have that might seem useless to you now can save lives elsewhere. Seeing the genuine smiles of a people so poor and destitute, grateful for even a gentle touch, makes one realize we really have nothing in comparison to complain about.

Any help would be greatly appreciated and will literally save lives. Bandages and supplies are always in short supply. My old microscope will be traveling to Africa in the next few months. If you want to give your kids something to do for someone else, take your old bed sheets, cut them in 4-inch strips and roll them tightly for bandages. They have no throw-away gauze bandages there. Cloth here is much superior, since their cloth has too much lint. Bandages with Smurfs, Mickey Mouse, Superman or other cartoon characters are prized greatly by little ones and bring smiles to tiny faces.

Already today, I have fought with workers’ comp, collections are still low and I’ve had to deal with an unhappy patient. You know, for some reason though, today just seems to be going better than Friday.

BY DANIEL E. LOLLAR, DC

DR. DANIEL LOLLAR is a 1981 graduate of the National College of Chiropractic. He has practiced in Toledo, Ohio for the past eight years and works closely with many physicians in multiple disciplines. Contact Dr. Lollar with questions or comments at [email protected].

Copyright Dynamic Chiropractic Sep 9, 2008

(c) 2008 Dynamic Chiropractic. Provided by ProQuest LLC. All rights Reserved.

Elderly Don’t Seek Help for Hoarseness

The breathy, hoarse voice of seniors is often considered a normal sign of aging, but U.S. doctors say it’s a false perception, U.S. researchers say.

Lead author Dr. Seth Cohen, an otolaryngologist at the Duke Voice Care Center found nearly 20 percent of the 248 octogenarians studied had dysphonia — the medical term for hoarseness, weakness or loss of voice. Fourteen percent had dysphagia or painful swallowing, more than 77 percent had hoarseness and 79 percent had dysphasia — language disorder in which there is an impairment of speech — but had not sought treatment, even though more than half expressed interest in getting treatment.

Half of those surveyed were unaware that treatment existed. This is a concern, said Cohen, because voice and swallowing concerns can lead to serious quality of life issues, including anxiety, depression and social withdrawal.

Cohen, who didn’t outline treatments that are available, said part of the problem may be under-recognition. Primary care physicians are currently managing the many medical conditions elderly people routinely face, and may not be discussing voice and swallowing problems with their patients.

“Our results highlight the need for better education of the general public and, primary care providers,” Cohen told the annual meeting of the American Academy of Otolaryngology — Head and Neck Surgery in Chicago.

Students, Nation Have Much to Learn

By JULIA GREGG

In a recent Public Broadcasting special, Judy Woodruff asked if U.S. students are ready to compete in the global community. In “Where We Stand: America’s Schools in the 21st Century,” Woodruff reports that of 30 developed countries, the U.S. ranks No. 25 in math and 21 in science.

Between 1995 and 2005, we slipped from first place to 15th in the number of college graduates worldwide. By 2015, China should have twice as many college graduates as the United States.

Part of the problem is economic. In the U.S., tuition at public colleges has doubled in the last two decades, and individuals must struggle to bear the tuition burden. In contrast, China, Finland and other competitive countries with rigorous academic standards provide student tuition.

Even in elementary and secondary schools in America, only 10 percent of funding comes from the federal government. In addition, we have few nationwide standards. Mississippi, for example, makes up its own state competency standards and has an 89 percent passing rate on state competency tests. Massachusetts has entirely different standards and a lower passing rate.

Standards and cut-off scores for much of America’s mandated testing are internally set, state by state, and are neither comparable nor meaningful on a national or international level.

When standards are externally set, for example in Advanced Placement or International Baccalaureate courses, students are tested based on a comparison of skills set nationally or internationally.

Woodruff reports that 40 percent of America’s high schools don’t even offer college prep classes, and all across America teachers are recruited from the bottom third of university classes. Seventy-five percent of young Americans cannot identify Iran or Israel on a map. Forty-three percent can’t find Ohio.

A visiting teacher from

China tells Woodruff that students in China study about twice as many hours per day as students in the U.S.

“It’s a different work ethic,” he observes.

U.S. students certainly are equal to any educational challenge, but who will offer wise leadership and direction?

Woodruff suggests that this is a critical time for American education. Newly elected officials must set new educational agenda and priorities beginning this November.

We need leaders who understand that we have much to learn, not only from American educators currently in the classroom, but also from the rest of the world.

We need leaders who understand that the world has changed. American education, in many areas, has not.

Send e-mail to Julia Gregg at [email protected].

(c) 2008 Evansville Courier & Press. Provided by ProQuest LLC. All rights Reserved.

Head of John Muir’s Concord Campus to Retire

By Dana Guzzetti

Thomas Harlan, president and chief administrative officer of John Muir Medical Center-Concord Campus, will give up his 80-hour work week for a little consulting, travel and his new winemaking endeavor, labeled August Truth.

Orinda resident Harlan, 63, said, “We decided several months back that there are other priorities.”

He plans to begin retirement with his wife Ruth by visiting family in the eastern United States.

“I’m not going to just go to the beach and lie in the sun. I have gotten a few calls already (for consults),” he said.

Clearly, Harlan has savored his work as a health care administrator since joining then-Mt. Diablo Medical Center, part of John Muir Health, in 1999.

“I am most proud that we have reached our all-time highest patient satisfaction and quality scores,” he said. “We have been ranked in the top five hospitals in California for cardiac surgery for the past two years, and the Concord Campus ranked best in San Francisco, Oakland and Contra Costa for overall cardiac services and cardiac surgery.”

He was referring to scores by HealthGrades, a hospital rating system that also ranked the John Muir Health system in the top five in California for the past two years. Harlan expects when the new ratings are announced, they will be equal to or better than the results of the past.

Harlan considered the development of a long-range master plan for the Concord hospital and the groundbreaking for the six-level patient care tower at the Concord campus as other satisfying career landmarks.

J. Kendall Anderson, president and chief executive officer of John Muir Health, listed accomplishments under Harlan’s leadership – – the successful financial turnaround of the Concord campus in 2002; establishment of the hospitalist program; implementation of a new Emergency Department physician contract; consolidation of obstetrics at the Walnut Creek Campus; improvement in patient satisfaction; and donation of the Intuitive daVinci Robotic Surgical System — among the reasons for Concord City Council’s approval of the Cardiovascular Institute and new Emergency Department projects.

Harlan earned the American College of Healthcare Executives Senior Leadership Award during his career in Concord.

“Anyone who knows Tom has great admiration and respect for his intellect, thoughtfulness and composure. These leadership traits are consistent, whether he’s addressing real tough times or just normal tough times,” said Ken Meehan, executive vice president of hospital operations.

“Tom took the chief administrative officer job, at what was Mt. Diablo Medical Center, during a time of crisis and was able to set a tone of both understanding and honesty that earned him the trust of the physicians and employees.”

Harlan also made community involvement a cornerstone of his management style. Among groups he supported were the Greater Concord Chamber of Commerce, the Contra Costa/Alameda Section of the Hospital Council (chairman in 2005), the Hospital Council of Northern and Central California, and the American Heart Association East Bay.

Prior to joining the John Muir health system, he served 18 years as a senior executive at Pacific Presbyterian Medical Center (now California Pacific) in San Francisco, and eight years as chief executive officer of Chinese Hospital and Chinese Community Health Plan in San Francisco.

Since Sept. 3, Harlan has been busy helping his interim replacement, Thomas Hayes, become familiar with the position to be filled Sept. 27.

“There is a wonderful person who will be here,” Harlan said about Hayes.

With 25 years in hospital administration, Hayes retired last year from Fremont-Rideout Health Group in Yuba City, where he administered three acute care hospitals.

Harlan said he believes it will take a few months to find a permanent replacement.

“After 40 years in executive-level health care management, my decision to retire at this time has been very difficult.”

Having said that, Harlan then looked forward to his next challenge, describing how he and his wife, Ruth, chose the name, August Truth, for their new winemaking venture — “Truth came from Tom and Ruth.”

(c) 2008 Oakland Tribune. Provided by ProQuest LLC. All rights Reserved.

Better Nutrition Announces Winners of Their Best of Supplements Awards

EL SEGUNDO, Calif., Sept. 24 /PRNewswire/ — Better Nutrition, (http://www.betternutrition.com/), the country’s leading independent health food store magazine, today announces the winners of their Best of Supplements Awards. The awards recognize 50 outstanding supplement products in categories ranging from heart health and immunity to pain relief and cancer prevention.

“Our goal is to give health food store shoppers recommendations of high-quality, effective products in a range of categories,” says Nicole Brechka, Better Nutrition’s editor-in-chief. “Shopping for supplements isn’t always easy; in fact, it’s often an overwhelming experience. Our Best of Supplements Awards will help shoppers walk away feeling confident about their purchases, as well as expose them to new products.”

To select the winning products, Better Nutrition conducted extensive interviews with a panel of experts, including naturopaths, medical doctors, and experts in the supplement industry. These experts also completed a comprehensive supplement survey and provided feedback on various supplements in 31 categories.

“Once we unveiled our Better Nutrition Best of Beauty Awards earlier this year, we had an overwhelming consumer demand for the same program focused on the supplement category,” says Joanna Shirk, publisher of Better Nutrition. “The natural products industry grew more than 9.8% in 2007 to more than $62 billion in sales. Together with the independent natural product store, Better Nutrition can act as a catalyst to influence purchasing decisions and raise brand consciousness for the premier products in the industry.”

The Awards will be featured in the November 2008 issue of Better Nutrition. The program includes an in-store marketing campaign, shelf talkers, and reprints of the “Best of Supplements” article in 1,200 retail locations nationwide.

“We expect that the Best of Supplements Awards will carry significant weight with Better Nutrition readers, translating into increased sales for both the retailer and the product manufacturer,” adds Shirk.

About Better Nutrition: Since 1938, Better Nutrition’s mission has been to responsibly inform health-food store shoppers about the latest breakthroughs in nutritional approaches to optimal health and ongoing research into vitamins, botanicals (herbs), minerals, and other supplements. Better Nutrition provides the link between the consumer reader interested in better nutrition, your independent health-food store, and the products carefully formulated by natural-product companies.

Better Nutrition endorses high-quality research and sensible nutrition. The magazine does not endorse any supplements. Better Nutrition is published by Active Interest Media (http://www.aimmedia.com/), in El Segundo, CA.

Better Nutrition

CONTACT: Dayna Macy, +1-415-591-0555, Ext. 304, [email protected], forBetter Nutrition

Web site: http://www.betternutrition.com/

Bedford Teen in Fight for Lyme Funds

By CHRISTINE McCONVILLE

After losing a third of her life to Lyme disease, Marlena Connors is eager to catch up with her peers.

She’s working to get her high school diploma and telling people about the six-year health odyssey that began with a red welt the diameter of a grapefruit on her back.

Diagnosed at age 13 with late-stage Lyme disease, Marlena was so sick that she had to leave school and quit ballet. Now 18, she’s mostly healthy.

Marlena and her family, who live in Bedford, play a significant role in the documentary, “Under Our Skin.” It aims to raise awareness of a disease that some say is woefully misdiagnosed.

The National Capital Lyme and Tick-Borne Disease Association will show portions of the film on Capitol Hill during a congressional hearing today on the disease. The national advocacy group and patients – including the Connors – will ask Congress to take another look at Lyme.

It has been more than 15 years since Congress last examined the disease, and members of the national committee hope that a new review will lead to better diagnostic tools, more research funding, and a stronger push for a cure.

Activists also want to have late-stage Lyme disease reclassified as a chronic illness, a move that would require health-insurance companies to pay for long-term antibiotic therapy. So far, the effort hasn’t been successful; some medical organizations deny that it is a chronic disease, while others say such treatment could be harmful.

Lyme disease is transmitted to humans from bacteria-infested blacklegged ticks. It is named after the Connecticut town where there was a well-known outbreak in 1975.

Symptoms include fever, headache, fatigue and skin rashes. If left untreated, the infection can spread to joints, the heart and nervous system.

According to the Centers for Disease Control and Prevention, some 20,000 people acquire the disease each year, and most are successfully treated with a few weeks of antibiotics.

Marlena Connors’ mother Sandra disputes that. She said yesterday that the disease has reached epidemic levels, but because it is so frequently misdiagnosed and under-reported, the government isn’t aware of how prevalent it is.

Even as Marlena’s rash spread and her temperature soared, the Connors’ doctor declined to test the girl for Lyme disease.

“He said the test had too many false positives,” she said.

Six months later, after Marlena’s knees and ankles had swollen, another physician determined that she had late-stage Lyme disease.

As her parents searched for effective treatment, Marlena found her body frequently shut down, and she became increasingly isolated.

It was at the world premier of “Under Our Skin,” in New York City, that she met – for the first time – other Lyme disease sufferers.

“I know it sounds strange,” she said, “but that was awesome.”

CAPTION: BETTER NOW: Lyme disease victim Marlena Connors, seen here with her mother, Sandra, stars in a film that will screen at a congressional hearing today. STAFF PHOTO BY MARK GARFINKEL

Originally published by By CHRISTINE McCONVILLE.

(c) 2008 Boston Herald. Provided by ProQuest LLC. All rights Reserved.

Socialist Reform Changes Lives of Bolivian Farmers

The fate of Bolivian farmers such as Julio Mamani hang in the balance amid erupting violence this month following leftist reforms put in place by President Evo Morales.

Morales, the country’s first Indian president, has increased state control of the nation’s economy, and has distributed roughly 2.47 million acres of land to indigenous peasants.

“Because I don’t own land I feel like I’ve got nothing in life,” 44 year old Mamani said.

“Thanks to Evo we’re going to have a piece of the land that belongs to big land owners.”

Mamani currently lives in a shack roughly 50 miles north of La Paz, where frost, drought and hailstorms regularly devastate crops.  He burns cow dung to obtain heat and works the land of others to make his living, which amounts to the equivalent of about $2 per day.  

Under Morales’ new land redistribution proposal, dozens of families in Achacachi have been promised land in the tropical lowlands in eastern Bolivia.

However, that plan, along with Morales’ broader socialist program, caused a violent reaction by large farming families in the country’s eastern agricultural heartland.  The opposition has occupied many government buildings and blocked highways, and 13 people have been killed in the violence according to local media reports.

So far, Morales has distributed only government land, but under a newly proposed constitution a limit on land ownership would be cut from 123,600 acres to 12,360 acres, which would lead to the redistribution of private land.

Bolivia’s wealth was traditionally held in the silver mines high in the Andes. However, families from Asia, Europe and elsewhere moved into the eastern lowlands during the 1960s and converted the area into a breadbasket of rice, soy, sugar and beef.

Today, the country remains divided between wealthier white people in the fertile lowlands and poor indigenous people in the western highlands, with about 1 percent of landowners owning 66 percent of the agricultural land.

“Not for a minute have we hesitated in our rejection of agrarian reform,” said Guido Nayar, who leads a prominent agriculture federation in the opposition stronghold of Santa Cruz.

“They want to limit property for those who produce food but not for those who produce drugs,” he said, referring to the coca leaf, the main ingredient of cocaine.

Indians use in the coca leaf in rituals and chew it to ward of hunger, a practice Morales, a former coca grower, has actively encouraged.

Almost all Latin American countries have attempted at some point to change systems in which a small number of elites own most of the land. 

Those elites traditionally opposed such initiatives, and even took down presidents who instituted agrarian reform, sometimes with U.S. support.
Morales expelled the U.S. ambassador earlier this month, claiming the United States was endorsing the opposition protests in an attempt to destabilize him.  

Nayar said Morales was trying to implement a 1950s model for agrarian reform that contradicts modern, consolidated agriculture, sentiments echoed in places like Mexico, where land redistribution has resulted in farms too small in some cases to even provide for a single family.

However, Morales has the backing of other Latin American leaders, and has vowed to move ahead with his plans.  

After taking office in January 2006, Morales first nationalized Bolivia’s energy sector, mining projects and the nation’s largest telecom company.  He used the proceeds of these widely popular measures to combat poverty.   Morales won 67 percent backing in a vote in August, despite resistance in eastern Bolivia.

“We’re starting the repossession process. It will be the end … of large idle land holdings,” Cliver Rocha, head of the government land reform office, told Reuters.

The Bolivian government wants to redistribute more than 19.77 million acres of land to more than 200,000 families by 2011.  To accomplish this the government will need to complete surveys and then seize any land it determines is either illegally owned or idle.

According to Rocha, the focus will be on land grants to “the historically dispossessed.”  However, unlike Bolivia’s last significant land reform effort in 1953, the current campaign will not allow people to sell their land, which will prevent speculation, he said.

Silverio Vera of the land rights group Landless Movement said roughly 180 families are better off after relocating to Santa Cruz and establishing a community called “Pueblos Unidos” on state land.  

“We have a school, small clinics, water tanks and we are sowing … The families are doing well because we have access to work.”

In Achacachi, where Morales received nearly 100 percent of the vote in August, Mamani hoped for a better life for his family in Santa Cruz.

“With land and hard work we’ll be able to move forward,” he told Reuters, adding that he won’t miss the extreme cold of the Andes, where his family has lived for generations.

“I’m going to take a small picture of the mountains as a souvenir and I’ll be fine looking at the picture.”

Image Courtesy Of Google

—-

On The Net:

Evo Morales

‘If We Are Determined to Break the Cycle of Inactivity, We Must Develop Motivating Initiatives’

Comment

August must have been the most exciting sporting month in our national consciousness in living memory (rivalled only by that marvellous month in 1966).

Our Olympians (and more recently our Paralympians) showed the world that we can be world leaders if we focus on results and have a clear strategy, which is underpinned by a financial and professional commitment by all stakeholders – from the Government to those responsible for managing the implementation of a plan designed to bridge that gap between goal and delivery.

We now need to bring the same focus to swopping our silver medal in the Obesity Olympics (coming second only to the US), for a gold in delivering a successful national public health strategy. However, when trying to improve the health of the nation we must not allow a preoccupation with diets and food management to become the default setting. Diet alone did not shape our world class athletes and our national obsession with the “energy in” side of the health and well- being equation will not solve our obesity crisis.

What we need is a paradigm shift in strategy and a focus on creating a balance between “energy in” (the food we eat) and “energy out” (the exercise we take). Around 50 per cent of the British public are already profoundly inactive, a factor which is set to bankrupt the NHS by 2050 and contribute not just to obesity – which will affect 50 per cent of the population by 2050 – but also over- 20 lifestyle diseases, which include Type 2 diabetes and asthma. Extensive research tells us that the risk of these diseases can be significantly reduced by a regular exercise regime.

If we are serious about changing the behaviours and attitudes towards food and activity among the 50 per centers, then we have to persuade them to be more active and live more healthily. It is not enough to “tell” an overweight or obese person, who is probably moderately or profoundly inactive, to walk up the stairs rather than take a lift or to get off one stop early and walk a little. They will listen but will not hear that sermon.

If we are determined to break the cycle of “inactivity”, then we have to develop initiatives that will excite, motivate, kick-start their activity habits and help sustain their new lifestyle. This community needs clear achievable goals that they know, understand and agree to. We have to be there when they fall off their new lifestyle wagon and be there to help them back onto it. We have to understand what their individual emotional and psychological drivers are and play to them. When we teach a child to read we start with the alphabet, then gently migrate them through a series of books of ever increasing complexity. We do not throw Little Dorrit at them and tell them to get on with it. We should use the same approach with someone who is not physically literate. We have to review and cheer their progress and map out their journey in small achievable increments, rather than just tell them to “Use the stairs. Go on. It’s good for you.”

The Government has already started to use this intervention process. It has earmarked significant funds for a one-year programme designed to get 10,000 16-22 year olds fitter and healthier and, working with the FIA, it plans to roll these out in five local authority areas, across the country. Catalysts like this are vital because just as the National Lottery underpinned the success of our current cadre of world-class athletes, so will investment in the physical health of the nation reap major rewards.

The national assets we have at our disposal include around 40,000 trained exercise professionals who have the experience, the expertise and the desire to work with schoolchildren, adolescents, adults and the over-fifties. We also have over 5,700 leisure centres and gyms that are no more than two miles from almost 90 per cent of the population and a further 10,000-odd “active places”, so why are they not fully deployed in the war on obesity and the other lifestyle diseases?

What we therefore need is a prevention-focused national strategy that addresses the “energy in” side of the health and wellbeing equation, as well as the “energy out” side.

However, the solution does not just lie in the corridors of Westminster, but with all of us. Employers have a responsibility to encourage their employees to be more active and lead healthier lives. The spectre of the credit crunch should not force this issue off the corporate agenda, because an active workforce is more productive, more motivated, more loyal and is absent less often. However, we too have a responsibility to ourselves and to those we care for.

This is the holistic approach which should underpin our “2012 Health Legacy” strategy and ensure that we hand that unwanted silver medal to another nation.

(c) 2008 Independent, The; London (UK). Provided by ProQuest LLC. All rights Reserved.

BayCare Health Selects Fujitsu Palm Vein Authentication Devices

Fujitsu Computer Products of America has announced that BayCare Health System has used the Fujitsu PalmSecure palm vein authentication devices as a part of its patient registration and identification process.

According to Fujitsu Computer Products, HT Systems’s PatientSecure integrates Fujitsu PalmSecure with Siemens Invision and Signature Hospital Information Systems, to provide patient identification management software that provides BayCare with a verification method for identifying patients. The combined solution helps protect patient privacy, safeguard Electronic Medical Records (EMRs), help to prevent medical identify theft and enables patients to receive care more efficiently. HT Systems is a healthcare technology company.

Fujitsu Computer Products claims that the combined solution enables BayCare to provide prompt and accurate patient identification. By doing so, BayCare is protecting each patient’s privacy while simultaneously accelerating patient identification without the use of sensitive information or usage of identification at all. In addition, in emergency situations, BayCare can identify patients even if they are confused or unconscious.

With the integration into its Siemens Invision and Signature systems, BayCare is able to stop duplicate medical records from being created. Since only one medical record can be linked to a single palm vein pattern, the patients essentially retrieve their own medical record with the palm of their hand. Not only does this keep the patient’s medical record secure, but reduces the cost associated with managing the combining of duplicated medical records, said Fujitsu Computer Products.

David Wiener, vice president, corporate vice president of sales at HT Systems, said: “The ability to identify John or Jane Doe’s is a powerful feature especially during the summer months when children are out from school. In addition, it allows BayCare to be one of the few hospitals that complies with The Joint Commission’s number one Patient Safety Goal, which is to improve the accuracy of patient identification.”

Pharmacist, Consultant Encourage Proactive Education, Understanding of Fertility Health

Experts at Village Fertility Pharmacy (www.villagefertilitypharmacy.com), a specialty pharmacy focused exclusively on medications for infertility treatments, and its partnering companies are encouraging men and women to be proactive about their fertility health as part of National Infertility Awareness Week from Oct. 19 to 25.

Regardless of whether or not individuals would like to have a baby in the near future or in five years, 20-year fertility pharmacist and Village Fertility Pharmacy President Stuart Levine said preemptive fertility testing and education can increase success rates by accelerating the start of treatment, reducing stress, and preparing infertility patients for the costs and procedures involved with infertility treatments.

“If a person knows that they want to pursue these treatments, they will do their homework and learn that they can be upwards of $15,000 per cycle, determine how much their insurance will pay, or start saving,” said Levine. “I’ve seen people change jobs or move to different states to get more coverage. Assisted reproductive treatments (ART) can be quite costly, so planning ahead can help speed the process along and reduce sticker shock.”

Both Levine and Angie Best-Boss, fertility author and president of My Fertility Plan, an infertility consulting firm, said many people try to conceive for years and tend to wait too long to investigate their infertility. This delay then results in a reactive decision to undergo infertility treatments, which incites unnecessary stress and can cause patients to be undereducated about the process.

“If you have diminished fertility due to age, health or lifestyle factors, knowing so before you’re ready to begin baby-making allows you to make the most informed decisions possible,” said Best-Boss.

Levine recommends starting with over-the-counter fertility tests, and both he and Best-Boss said men and women should have regular medical checkups to ensure that chronic diseases and untreated or undiagnosed sexually transmitted infections don’t lead to infertility.

“To be proactive is to be prepared. Infertility, its treatments and medications can be a lot to grasp,” said Levine. “By educating yourself and understanding your fertility health well before you are ready to have children, you will undoubtedly increase your chance for success.”

For information about Village Fertility Pharmacy, visit www.villagefertilitypharmacy.com or call (877) 334-1610. For information about My Fertility Plan, email [email protected] or call (877) 509-PLAN.

About Village Fertility Pharmacy

Village Fertility Pharmacy is a pharmacist-owned and operated specialty pharmacy dedicated to offering the best service and education to infertility patients and clinics. In operation for more than 20 years, Village’s knowledgeable staff has developed a deep understanding of the complicated nature of infertility medications and treatments, and the unique needs of infertility patients. To extend its relationships with patients, Village has created an online store at www.villagefertilityproducts.com. For information about the company, visit www.villagefertilitypharmacy.com.

 Contact: Marci J. Hait Matter Communications, Inc. (978) 499-9250 Ext. 238 Email Contact

SOURCE: Village Fertility Pharmacy

OBS Medical Receives New FDA 510(K) Clearance Expanding Visensia Solutions for Hospital Patient Safety

OBS Medical announced today that the Food and Drug Administration has granted 510(k) clearance for the company to market its Visensia(R) Alert (VitalAlert(TM)) in the United States.

Formerly know as BioSign, Visensia’s automated early warning technology fuses up to five vital signs – heart rate, respiration rate, body temperature, oxygen saturation and blood pressure – into a numerical index. The Visensia Index is an indication of a patient’s wellness and can enable significant improvement in clinical outcomes and optimization of hospital resource utilization. When the Index reaches and/or surpasses the default threshold, the VitalAlert is triggered.

“Clinical workflow in today’s hospital is stricken by high rates of monitor false alarms, compromising patient safety and increasing operational costs,” says Frank Cheng, President and CEO of OBS Medical. “As confirmed by recently published data from a large-scale, award-winning clinical study, Visensia VitalAlert(TM) can enable a high-precision alerting process resulting in reliable identification of patient crisis.”

Archives of Internal Medicine, a peer-reviewed journal of the American Medical Association (AMA), published the results of this patient safety study on June 23. The paper, “Defining the Incidence of Cardiorespiratory Instability in Patients in Step-down Units Using an Electronic Integrated Monitoring System”, is based on initial results from a 1,000+ patient study conducted at University of Pittsburgh Medical Center (UPMC). This is the largest ever continuous monitoring study for cardiorespiratory variables in the non-ICU setting, and Phase I of this study included 300+ patients with 18,800+ hours of continuous monitoring.

This new evidence supports Visensia’s early detection of clinical instability and prevention of crisis. UPMC has a long-standing, world-class Medical Emergency Team (MET). Of the clinical events requiring MET activation, Visensia detected 100% and provided an early warning (average 6.3 hours) of patients’ deterioration. Overall, the Visensia Index crossed the alert threshold only 4.25 times per day for the 24-bed unit, proving VitalAlert’s effective specificity (very low false alerts).

To help improve nursing productivity, Visensia VitalAlert can be programmed to trigger audio/visual alerts at bedside, central station, pagers, phones, and nurse communication systems.

About OBS Medical

OBS Medical delivers life-saving insight through its innovative clinical solutions for safer hospitals, safer patients and safer drugs. Based on intelligent algorithms such as neural networks, data fusion and waveform recognition, these technologies cover a range of medical applications including automated early crisis warning (Visensia(R)) and efficient cardiac safety for pharmaceutical research and development (BioQT(TM)). OBS Medical is in Carmel, Indiana and is a wholly-owned subsidiary of Oxford BioSignals Ltd. based in Oxford, UK, which was originally spun out from Oxford University.

Lance Armstrong Unveils Global Cancer Awareness Campaign and Details of His Return to Cycling

Today, Lance Armstrong, cancer survivor, cycling champion and founder and chairman of the Lance Armstrong Foundation (LAF), announced the creation of the LIVESTRONG(TM) Global Cancer Awareness Campaign focused on supporting the 25 million people living with cancer worldwide, dispelling the misconceptions surrounding the disease and urging world leaders to make cancer a greater priority.

“I’m returning to cycling in order to raise awareness of the global cancer burden,” said Mr. Armstrong. “While my intention is to train and compete as fiercely as I always have, this time I will gauge victory by how much progress we make against cancer, a disease that will claim 8 million lives this year alone. Our campaign will appeal to every person affected by cancer as well as their nations’ leaders and we intend to visit, race and train in those countries that join our cause. We will reach out to those who suffer in silence and connect them with a community of cancer survivors to give them strength and hope. And we will appeal to world leaders, asking for their help in fighting a disease from which millions die needlessly. United, we can win the fight against cancer.”

Cancer is a leading cause of death that is projected to claim 12 million lives by 2030. Deaths due to cancer outnumber those caused by AIDS, tuberculosis and malaria combined. Following 18 months of worldwide research, the LAF found widespread misconceptions, stigma and lack of awareness associated with cancer. For many countries, cancer is considered a death sentence, causing people to avoid seeking prevention, detection and treatment. Because many still believe cancer to be contagious, those affected by the disease are frequently isolated and stigmatized by their communities. Often, the causes of the disease and the growing success in treating cancer are unknown.

Mr. Armstrong unveiled the LIVESTRONG(TM) Global Cancer Awareness Campaign before world leaders, policy makers and non-profit organizations gathered at the opening session of the Clinton Global Initiative in New York. Speaking to attendees, Mr. Armstrong appealed for their support and invited them to attend the LIVESTRONG(TM) Global Cancer Summit, scheduled for July 28, 2009, in Paris, following the Tour de France.

“I am so pleased that Lance Armstrong and his foundation made a commitment to increase their efforts to raise awareness and inspire action to fight cancer on a global scale,” President Clinton said. “This campaign is a great example of what can be done to address pressing challenges in new and measurable ways — which is what the Clinton Global Initiative is all about.”

New York City Mayor Michael Bloomberg was among the first to lend his support to raising cancer awareness around the world.

“Tens of millions of eyes will be on the Tour, and this is our chance to captivate a captive audience,” said Mayor Bloomberg. “Awareness is a key to cancer prevention and this is a once-in-a-lifetime opportunity to make people aware of what they can do and how they can get involved.”

Mr. Armstrong also revealed details of his return to cycling. He will be reuniting with Johan Bruyneel, his long time team director and the architect of his seven Tour de France wins, on Team Astana. Mr. Armstrong described a rekindled desire throughout the past year to reengage in professional cycling. His commitment to the sport and to its growth is exemplified by his long-term partnership with Mr. Bruyneel as a Pro Tour rider and owner, as a mentor and owner of the Trek Under 23 Developmental Team, and as a local owner of a bike shop in Austin, Texas.

Mr. Armstrong also announced his commitment to changing the culture of drug testing in professional sports through his team’s retention of Dr. Don Catlin, a leading expert in identifying and detecting the use of performance enhancing drugs in professional sports. Dr. Catlin will design the most comprehensive program ever implemented for a professional athlete. The goal of the program will be to change current thinking about testing and make it possible for athletes to prove they are racing clean rather than trying to prove they did not cheat. All of Lance’s blood work and testing will be posted online at www.livestrong.com.

“Lance has been very specific about his desire for the complete transparency and availability of his results,” said Dr. Catlin. “The program we have developed for him will be thorough, rigorous and leave no room for speculation.”

Mr. Armstrong also announced highlights of his racing schedule which will include the Tour Down Under in Australia beginning January 18, 2009 (his first race since the 2005 Tour de France), and the Tour de France which begins July 4, 2009, in Monaco.

Biography: Don Catlin, M.D., CEO of Anti-Doping Research & Professor Emeritus at the UCLA School of Medicine

For 26 years, Dr. Don Catlin has been at the forefront of the global battle against the use of performance-enhancing drugs in sports, and he is often referred to as one of the fathers of drug testing in sport. In 1982, Dr. Catlin founded the UCLA Olympic Analytical Laboratory, the first anti-doping lab in the United States, and served as its director for 25 years. Under his stewardship, the lab grew to become the world’s largest.

At the UCLA Olympic Lab, Dr. Catlin oversaw the drug testing at the 1984 Summer Olympic Games in Los Angeles, the 2002 Winter Games in Salt Lake City, the 1994 Soccer World Cup and the testing for anabolic agents at the 1996 Summer Games in Atlanta. Among other breakthroughs, he and his lab team developed the testing methodology that differentiates natural from artificial testosterone; inaugurated the test for darbepoetin, a long-acting form of the blood booster medicine EPO; were first to report the use of a designer steroid (norbolethone) in sport; and marshaled the analytic work behind the BALCO scandal, which involved identifying the designer steroid THG.

In 2005, as part of an effort to keep up with the continual introduction of new and ever-evolving performance-enhancing drugs in competition, Dr. Catlin and colleagues founded Anti-Doping Research (ADR), a non-profit organization dedicated to research and testing development. One of ADR’s current priorities is developing a reliable urine test to detect the use of human growth hormone (hGH) — a long-sought-after goal that Dr. Catlin believes is within reach.

Dr. Catlin also serves as Professor Emeritus of Molecular and Medical Pharmacology at the UCLA School of Medicine and is the author of over 100 articles in scientific publications. He is a member of the World Anti-Doping Agency Health, Medical and Research Committee and a member of the International Olympic Committee Medical Commission, the two organizations charged with oversight of the drug testing at the 2008 Summer Olympic Games in Beijing.

About the Lance Armstrong Foundation

The Lance Armstrong Foundation (LAF) unites people through programs and experiences to empower cancer survivors to live life on their own terms and to raise awareness and funds for the fight against cancer. The LAF focuses on cancer prevention, access to screening and care, research and quality of life for cancer survivors. Founded in 1997 by cancer survivor and champion cyclist Lance Armstrong, the LAF has raised more than $260 million for the fight against cancer and distributed more than 60 million LIVESTRONG(TM) wristbands to help make cancer a global priority. This year, the LAF became a supporter of the World Cancer Declaration endorsed by the UICC World Cancer Congress 2008. The LAF encourages all individuals to show their support by signing the declaration at www.livestrong.org.

 Contact: Katherine McLane Lance Armstrong Foundation (512) 279-8384 Email Contact  Mark Higgins Capital Sports & Entertainment (512) 370-1919 Email Contact

SOURCE: Lance Armstrong Foundation

Dallas Cardiologists Explore ‘Next Frontier’ in Vascular-Disease Treatments

DALLAS, Sept. 24 /PRNewswire-USNewswire/ — Presbyterian Hospital of Dallas is one of only a handful of medical centers in the United States — and the only Texas facility — to broadcast live interventional cases to the prestigious Vascular InterVentional Advances conference, held this week in Las Vegas, Nev.

The VIVA conference will educate over 1,000 physicians and medical personnel on the latest advances in the treatment of peripheral vascular disease (PVD), a looming health crisis as the U.S. population ages and more Americans battle obesity.

Drs. Tony Das and James Park, interventional cardiologists at Presbyterian Hospital of Dallas, will perform cases from Presbyterian’s cardiac catheterization lab. The procedures will be transmitted in high-definition to the conference in Las Vegas, where cardiac experts from around the world will be assembled.

“With the prevalence of diabetes and obesity among an already aging population, the challenges facing those involved in the diagnosis and treatment of peripheral vascular disease are overwhelming,” Dr. Das said. “It’s a problem that will increasingly challenge medical experts around the country in coming years.”

Other sites for live cases include The Cleveland Clinic and the University of California Davis Medical Center.

PVD is a common condition affecting more than 10 million adults in the United States. The condition is a disease of blood vessels outside the heart and brain characterized by a narrowing of vessels that carry blood to the legs, arms, stomach and kidney.

The live cases from Presbyterian will demonstrate complex vascular procedures to open and stent arteries supplying the kidneys, focusing part of their session on the increase in renal artery disease in the United States. Other cases will focus on techniques to open complex blockages of the femoral and tibial arteries, which supply blood to the lower limbs. If untreated, the condition can lead to tissue and limb loss.

A new technique to treat these blockages involves using a tiny crown coated with diamond chips that rapidly spins at high speeds and sands away plaque inside arteries — while preserving the healthy tissue of the arterial wall. Orbital rotational force causes the tip of the device to expand inside the artery as it slowly sands away plaque and opens the artery to restore proper blood flow.

“These treatments are among our best tools to treat peripheral vascular disease and restore blood flow to the legs and feet,” said Dr. Kenneth Saland, an interventional cardiologist at Presbyterian who will perform cases during the conference. “Advanced treatments like these are keys to effective limb salvage.”

The Research and Education Institute for Texas Health Resources (TREI) provided technical support and assistance in the preparation and production for this event to happen through the Presbyterian Institute for Minimally Invasive Technology (PIMIT).

Texas Health Resources

CONTACT: Stephen O’Brien, Public Relations manager, Texas HealthResources, +1-214-345-4960, +1-214-759-2584 (Pager),[email protected]

Web Site: http://www.texashealth.org/

Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents

PURCHASE, N.Y., Sept. 24 /PRNewswire/ — A new paper published in Nutrition Reviews (Vol. 66(9):526-531) by Dr. Barry W. Ritz, PhD, Department of Bioscience and Biotechnology at Drexel University, has shown how AHCC impacts the immune response against a number of infectious agents.

The scientific review analyzed outcomes from in vivo studies evaluating the effect of AHCC supplementation on immune response following challenge with a variety of infectious agents such as the influenza (flu) virus, avian influenza (bird flu), Methicillin-Resistant Staphylococcus aureus (MRSA), Klebsiella pnuemoniae and Candida albicans. It was reported that supplementation with AHCC modulated immunity and delivered positive results in response to acute virus and bacterial infections.

“Studies with AHCC in multiple models of infectious disease, including the viruses that cause seasonal flu and bird flu, suggest that AHCC can stimulate the immune system and help the body respond to a broad spectrum of infectious threats,” says Barry Ritz, Ph.D., Professor of Bioscience and Biotechnology at Drexel University.

Research completed with AHCC has shown that it activates important immune white blood cells including macrophages, NK cells and LAK cells. AHCC also induces the production of cytokines that serve as chemical messengers between cells. AHCC has been the subject of over 80 research studies worldwide including studies completed at Harvard University’s Faulkner Hospital, Yale University and Columbia University Medical Center.

In addition to these studies, further investigation is being done examining the role of AHCC in humans for its ability to impact the T cells related to cellular immunity and determining if AHCC supplementation can serve as a beneficial vaccine adjuvant for the flu shot.

What is AHCC (Active Hexose Correlated Compound)?

AHCC is derived from the hybridization of several subspecies of medicinal mushroom, cultivated in Japan and then produced from a unique manufacturing process. AHCC is the leading immune-enhancing supplement in Japan and is utilized by over 700 hospitals and healthcare facilities worldwide as a standard preventative supplement for incoming patients to help reduce the risk of hospital infections as well as supporting the body’s fight against the formation of abnormal cells.*

AHCC is manufactured by Amino Up Chemical Company in Sapporo, Japan and is distributed in the United States by Maypro Industries. Maypro sells AHCC to a number of leading supplement companies including Quality of Life Laboratories, a subsidiary of Maypro.

The AHCC Research Association was founded in 1986 to promote further study. Each year since 1994, over 300 medical doctors and researchers have gathered in Sapporo, Japan for the AHCC Research Association Symposium to share and discuss the latest developments.

To learn more about AHCC, visit the AHCC Research Association Web site at http://www.ahccresearch.com/

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or mitigate disease.

AHCC Research Association

CONTACT: Steve Hanson of GRIP IDEAS, +1-602-430-7246,[email protected], for AHCC Research Association

Web Site: http://www.ahccresearch.com/